|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q88780571
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000339.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q88780571
|
|
024
|
|
|
‡a
0000-0002-5537-3387
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q88780571
|
|
100
|
0 |
|
‡a
Robert C G Martin
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Robert C G Martin
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma
|
|
670
|
|
|
‡a
Author's A cost analysis of early biliary strictures following orthotopic liver transplantation in the United States
|
|
670
|
|
|
‡a
Author's A cost analysis of somatostatin use in the prevention of pancreatic fistula after pancreatectomy
|
|
670
|
|
|
‡a
Author's A literature-based treatment algorithm for low-grade neuroendocrine liver metastases
|
|
670
|
|
|
‡a
Author's A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node
|
|
670
|
|
|
‡a
Author's A multi-institutional analysis of 429 patients undergoing major hepatectomy for colorectal cancer liver metastases: The impact of concomitant bile duct resection on survival
|
|
670
|
|
|
‡a
Author's A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?
|
|
670
|
|
|
‡a
Author's A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model
|
|
670
|
|
|
‡a
Author's A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium.
|
|
670
|
|
|
‡a
Author's A novel theranostic gold nanorods- and Adriamycin-loaded micelle for EpCAM targeting, laser ablation, and photoacoustic imaging of cancer stem cells in hepatocellular carcinoma
|
|
670
|
|
|
‡a
Author's A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma
|
|
670
|
|
|
‡a
Author's A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy
|
|
670
|
|
|
‡a
Author's A Proposed Staging System for Gastric Carcinoid Tumors Based on an Analysis of 1,543 Patients
|
|
670
|
|
|
‡a
Author's A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients
|
|
670
|
|
|
‡a
Author's A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients
|
|
670
|
|
|
‡a
Author's A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry
|
|
670
|
|
|
‡a
Author's A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety.
|
|
670
|
|
|
‡a
Author's A statin-regulated microRNA represses human c-Myc expression and function.
|
|
670
|
|
|
‡a
Author's Ablative therapies for colorectal liver metastases
|
|
670
|
|
|
‡a
Author's Acceptance of sentinel lymph node biopsy of the breast by all general surgeons in kentucky
|
|
670
|
|
|
‡a
Author's Achieving R0 resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?1 1No competing interests declared
|
|
670
|
|
|
‡a
Author's Actual 5-Year Survivors After Surgical Resection of Hilar Cholangiocarcinoma
|
|
670
|
|
|
‡a
Author's Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma
|
|
670
|
|
|
‡a
Author's Adequate lymphadenectomy results in accurate nodal staging without an increase in morbidity in patients with gastric adenocarcinoma
|
|
670
|
|
|
‡a
Author's Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?
|
|
670
|
|
|
‡a
Author's Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?
|
|
670
|
|
|
‡a
Author's Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.
|
|
670
|
|
|
‡a
Author's Adult Soft Tissue Ewing Sarcoma or Primitive Neuroectodermal Tumors
|
|
670
|
|
|
‡a
Author's Adverse outcomes and short-term cost implications of bile duct injury during cholecystectomy
|
|
670
|
|
|
‡a
Author's Age and Lymphovascular Invasion Accurately Predict Sentinel Lymph Node Metastasis in T2 Melanoma Patients
|
|
670
|
|
|
‡a
Author's Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma.
|
|
670
|
|
|
‡a
Author's An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system
|
|
670
|
|
|
‡a
Author's An evaluation of emergency general surgery transfers and a call for standardization of practices
|
|
670
|
|
|
‡a
Author's Analysis of 6,747 Pancreatic Neuroendocrine Tumors for a Proposed Staging System
|
|
670
|
|
|
‡a
Author's Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system
|
|
670
|
|
|
‡a
Author's Are 3 sentinel nodes sufficient?
|
|
670
|
|
|
‡a
Author's Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional Study
|
|
670
|
|
|
‡a
Author's Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes
|
|
670
|
|
|
‡a
Author's Assessing relative cost of complications following orthotopic liver transplant.
|
|
670
|
|
|
‡a
Author's Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer
|
|
670
|
|
|
‡a
Author's Assessing Trends in Palliative Surgery for Extrahepatic Biliary Malignancies: A 15-Year Multicenter Study
|
|
670
|
|
|
‡a
Author's Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor
|
|
670
|
|
|
‡a
Author's Assessment of mitotic rate reporting in melanoma
|
|
670
|
|
|
‡a
Author's Assessment of symptom experience in patients undergoing hepatic resection or ablation
|
|
670
|
|
|
‡a
Author's Assessment of the reporting of quality and outcome measures in hepatic resections: a call for 90-day reporting in all hepatectomy series
|
|
670
|
|
|
‡a
Author's Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival
|
|
670
|
|
|
‡a
Author's Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus.
|
|
670
|
|
|
‡a
Author's Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium.
|
|
670
|
|
|
‡a
Author's Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium
|
|
670
|
|
|
‡a
Author's Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium
|
|
670
|
|
|
‡a
Author's Association of Preoperative Risk Factors With Malignancy in Pancreatic Mucinous Cystic Neoplasms: A Multicenter Study
|
|
670
|
|
|
‡a
Author's Bile cultures: A guide to infectious complications after pancreaticoduodenectomy
|
|
670
|
|
|
‡a
Author's Biopsy type does not influence sentinel lymph node status
|
|
670
|
|
|
‡a
Author's Body mass index influences palpability but not stage of breast cancer at diagnosis
|
|
670
|
|
|
‡a
Author's Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation
|
|
670
|
|
|
‡a
Author's C-terminal deletion mutant p21
|
|
670
|
|
|
‡a
Author's C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells
|
|
670
|
|
|
‡a
Author's Calculation of breast volumes from mammogram: Comparison of four separate equations relative to mastectomy specimen volumes
|
|
670
|
|
|
‡a
Author's Carcinogenetic initiation contributed by EpCAM+ cancer cells in orthotopic HCC models of immunocompetent and athymic mice
|
|
670
|
|
|
‡a
Author's Cardiac synchronization and arrhythmia during irreversible electroporation
|
|
670
|
|
|
‡a
Author's Caudate lobe resections: a single-center experience and evaluation of factors predictive of outcomes
|
|
670
|
|
|
‡a
Author's Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.
|
|
670
|
|
|
‡a
Author's Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation.
|
|
670
|
|
|
‡a
Author's Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation.
|
|
670
|
|
|
‡a
Author's Chemopreventive drug treatment in subjects with genetic predisposition to cancer: prescriber liability and healthcare disparities
|
|
670
|
|
|
‡a
Author's Chemoprotective effects of Curcuma aromatica on esophageal carcinogenesis
|
|
670
|
|
|
‡a
Author's Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids
|
|
670
|
|
|
‡a
Author's Clinical effect of enoxaparin on international normalized ratio following hepato-pancreatico-biliary and gastroesophageal resection
|
|
670
|
|
|
‡a
Author's Clinical evaluation of somatostatin use in pancreatic resections: Clinical efficacy or limited benefit?
|
|
670
|
|
|
‡a
Author's Clinicopathologic and survival differences between upper and lower extremity melanomas.
|
|
670
|
|
|
‡a
Author's Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer
|
|
670
|
|
|
‡a
Author's Colocalization of MnSOD expression in response to oxidative stress
|
|
670
|
|
|
‡a
Author's Combined pancreas and liver therapies: resection and ablation in hepato-pancreatico-biliary malignancies.
|
|
670
|
|
|
‡a
Author's Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinoma
|
|
670
|
|
|
‡a
Author's Comparison of sentinel lymph node micrometastatic tumor burden measurements in melanoma
|
|
670
|
|
|
‡a
Author's Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy
|
|
670
|
|
|
‡a
Author's Complications of Jejunostomy Feeding Tubes: A Single Center Experience of 546 Cases
|
|
670
|
|
|
‡a
Author's Concomitant capecitabine with hepatic delivery of drug eluting beads in metastatic colorectal cancer.
|
|
670
|
|
|
‡a
Author's Conditional probability of long-term survival after resection of hilar cholangiocarcinoma
|
|
670
|
|
|
‡a
Author's Controlled release of curcumin from curcumin-loaded nanomicelles to prevent peritendinous adhesion during Achilles tendon healing in rats
|
|
670
|
|
|
‡a
Author's Correlating serum Alpha -fetoprotein in hepatocellular carcinoma with response to Yttrium-90 transarterial radioembolization with glass microspheres (TheraSphere™)
|
|
670
|
|
|
‡a
Author's Correlation between prognostic factors and increasing age in melanoma
|
|
670
|
|
|
‡a
Author's Correlation of Biliary Colic in the Absence of Cholelithiasis with Pancreaticobiliary Obstruction
|
|
670
|
|
|
‡a
Author's Cost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinoma
|
|
670
|
|
|
‡a
Author's CT Findings of Patients Treated with Irreversible Electroporation for Locally Advanced Pancreatic Cancer
|
|
670
|
|
|
‡a
Author's Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma
|
|
670
|
|
|
‡a
Author's Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium
|
|
670
|
|
|
‡a
Author's Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
|
|
670
|
|
|
‡a
Author's Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer
|
|
670
|
|
|
‡a
Author's Determinants of early distant metastatic disease in elderly patients with breast cancer
|
|
670
|
|
|
‡a
Author's Diet composition affects surgery-associated weight loss in rats with a compromised alimentary tract
|
|
670
|
|
|
‡a
Author's Dietary freeze-dried black raspberry's effect on cellular antioxidant status during reflux-induced esophagitis in rats
|
|
670
|
|
|
‡a
Author's Differences between bipolar compression and ultrasonic devices for parenchymal transection during laparoscopic liver resection
|
|
670
|
|
|
‡a
Author's Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer
|
|
670
|
|
|
‡a
Author's Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium
|
|
670
|
|
|
‡a
Author's Diversity of stage III melanoma in the era of sentinel lymph node biopsy
|
|
670
|
|
|
‡a
Author's Do melanoma patients from Southern climates have a worse outcome than those from Northern climates?
|
|
670
|
|
|
‡a
Author's Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?
|
|
670
|
|
|
‡a
Author's Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional Study
|
|
670
|
|
|
‡a
Author's Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma
|
|
670
|
|
|
‡a
Author's Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases
|
|
670
|
|
|
‡a
Author's Early nontumorous CT findings after irreversible electroporation of locally advanced pancreatic cancer
|
|
670
|
|
|
‡a
Author's Effect of freeze-dried berries on the development of reflux-induced esophageal adenocarcinoma.
|
|
670
|
|
|
‡a
Author's Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer
|
|
670
|
|
|
‡a
Author's Effect of multiple-nodal basin drainage on cutaneous melanoma.
|
|
670
|
|
|
‡a
Author's Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects
|
|
670
|
|
|
‡a
Author's Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases
|
|
670
|
|
|
‡a
Author's Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE).
|
|
670
|
|
|
‡a
Author's Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma
|
|
670
|
|
|
‡a
Author's Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.
|
|
670
|
|
|
‡a
Author's Empiric antibiotics for transarterial embolization in hepatocellular carcinoma: indicated?
|
|
670
|
|
|
‡a
Author's Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma
|
|
670
|
|
|
‡a
Author's Epidermal growth factor expression in esophageal adenocarcinoma: a clinically relevant target?
|
|
670
|
|
|
‡a
Author's Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma
|
|
670
|
|
|
‡a
Author's Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines: a target of chemoresistence
|
|
670
|
|
|
‡a
Author's ER stress and autophagy dysfunction contribute to fatty liver in diabetic mice
|
|
670
|
|
|
‡a
Author's Esophageal anastomotic leak does not affect ability to receive adjuvant treatment
|
|
670
|
|
|
‡a
Author's Esophageal carcinoma histology affects perioperative morbidity following open esophagogastrectomy
|
|
670
|
|
|
‡a
Author's Esophageal injury with external esophageal perfusion
|
|
670
|
|
|
‡a
Author's Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium.
|
|
670
|
|
|
‡a
Author's Evaluating the Regulatory Immunomodulation Effect of Irreversible Electroporation (IRE) in Pancreatic Adenocarcinoma
|
|
670
|
|
|
‡a
Author's Evaluation of Alpha -fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
|
|
670
|
|
|
‡a
Author's Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy
|
|
670
|
|
|
‡a
Author's Evaluation of Probe Angles for Synchronous Waveform 915-MHz Microwave Ablation
|
|
670
|
|
|
‡a
Author's Evaluation of quality of life following placement of self-expanding plastic stents as a bridge to surgery in patients receiving neoadjuvant therapy for esophageal cancer
|
|
670
|
|
|
‡a
Author's Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas
|
|
670
|
|
|
‡a
Author's Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
|
|
670
|
|
|
‡a
Author's Evaluation of tolerability and efficacy of irreversible electroporation
|
|
670
|
|
|
‡a
Author's Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
|
|
670
|
|
|
‡a
Author's Exposure to bile acids alters the intracellular location and function of MnSOD in Barrett's esophagus
|
|
670
|
|
|
‡a
Author's Extended local resection for advanced gastric cancer: increased survival versus increased morbidity
|
|
670
|
|
|
‡a
Author's Factors associated with false-negative sentinel lymph node biopsy in melanoma patients
|
|
670
|
|
|
‡a
Author's Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
|
|
670
|
|
|
‡a
Author's Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis
|
|
670
|
|
|
‡a
Author's Factors associated with surgical options for breast carcinoma
|
|
670
|
|
|
‡a
Author's Factors determining adequacy of axillary node dissection in breast cancer patients
|
|
670
|
|
|
‡a
Author's Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients
|
|
670
|
|
|
‡a
Author's Factors Influencing Time to Decrease in Intraoperative Parathyroid Hormone (ioPTH) Levels in Patients Undergoing Focused Parathyroidectomy (FP)
|
|
670
|
|
|
‡a
Author's Factors predicting failure to identify a sentinel lymph node in breast cancer
|
|
670
|
|
|
‡a
Author's Factors predictive of readmission after hepatic resection for hepatocellular carcinoma
|
|
670
|
|
|
‡a
Author's Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Bi
|
|
670
|
|
|
‡a
Author's Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling
|
|
670
|
|
|
‡a
Author's Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities
|
|
670
|
|
|
‡a
Author's Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable?
|
|
670
|
|
|
‡a
Author's Gastric-Esophageal Stenting for Malignant Dysphagia: Results of Prospective Clinical Trial Evaluation of Long-Term Gastroesophageal Reflux and Quality of Life-Related Symptoms
|
|
670
|
|
|
‡a
Author's Gastroesophageal reflux disease-related symptom assessment in subjects with malignant dysphagia receiving esophageal stents.
|
|
670
|
|
|
‡a
Author's Gender-related differences in outcome for melanoma patients
|
|
670
|
|
|
‡a
Author's Gold nanorods and curcumin-loaded nanomicelles for efficient in vivo photothermal therapy of Barrett's esophagus
|
|
670
|
|
|
‡a
Author's Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors
|
|
670
|
|
|
‡a
Author's Health-related quality of life changes following major and minor hepatic resection: the impact of complications and postoperative anemia
|
|
670
|
|
|
‡a
Author's Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin
|
|
670
|
|
|
‡a
Author's Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from ocular melanoma
|
|
670
|
|
|
‡a
Author's Health-related quality of life: return to baseline after major and minor liver resection.
|
|
670
|
|
|
‡a
Author's Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?
|
|
670
|
|
|
‡a
Author's Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis
|
|
670
|
|
|
‡a
Author's Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry
|
|
670
|
|
|
‡a
Author's Hepatic arterial therapy as a bridge to ablation or transplant in the treatment of hepatocellular carcinoma.
|
|
670
|
|
|
‡a
Author's Hepatic arterial therapy with drug-eluting beads in the management of metastatic bronchogenic carcinoma to the liver: a multi-institutional registry
|
|
670
|
|
|
‡a
Author's Hepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry
|
|
670
|
|
|
‡a
Author's Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma.
|
|
670
|
|
|
‡a
Author's Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study
|
|
670
|
|
|
‡a
Author's Hepatic intraductal oncocytic papillary carcinoma
|
|
670
|
|
|
‡a
Author's Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature
|
|
670
|
|
|
‡a
Author's Hepatic protection and anticancer activity of curcuma: a potential chemopreventive strategy against hepatocellular carcinoma
|
|
670
|
|
|
‡a
Author's Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial
|
|
670
|
|
|
‡a
Author's Herbal medicine and hepatocellular carcinoma: applications and challenges
|
|
670
|
|
|
‡a
Author's High N-acetyltransferase 1 (NAT1) expression is associated with estrogen receptor expression in breast tumors, but is not under direct regulation by estradiol, 17beta-diol, or dihydrotestosterone in breast cancer cells
|
|
670
|
|
|
‡a
Author's High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening
|
|
670
|
|
|
‡a
Author's Identifying risk factor for development of perioperative venous thromboembolism in patients with gastrointestinal malignancy
|
|
670
|
|
|
‡a
Author's Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin
|
|
670
|
|
|
‡a
Author's Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes
|
|
670
|
|
|
‡a
Author's Image of the month. Papillary low-grade neuroendocrine tumor of the pancreas with pancreatic duct dilation
|
|
670
|
|
|
‡a
Author's Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin
|
|
670
|
|
|
‡a
Author's Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry
|
|
670
|
|
|
‡a
Author's Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis
|
|
670
|
|
|
‡a
Author's Impact of histology on survival in retroperitoneal sarcomas
|
|
670
|
|
|
‡a
Author's Impact of Perfusate Glucose Concentration on Perioperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
|
|
670
|
|
|
‡a
Author's Impact of post-operative complications on quality of life after pancreatectomy
|
|
670
|
|
|
‡a
Author's Impact of surgical margin clearance for resection of secondary hepatic malignancies
|
|
670
|
|
|
‡a
Author's Implementation of Prehabilitation for Major Abdominal Surgery and Head and Neck Surgery: a Simplified Seven-Day Protocol
|
|
670
|
|
|
‡a
Author's Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis
|
|
670
|
|
|
‡a
Author's Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma
|
|
670
|
|
|
‡a
Author's Incomplete thermal ablation of hepatocellular carcinoma: effects on tumor proliferation
|
|
670
|
|
|
‡a
Author's Infectious complications in combined colon resection and ablation of colorectal liver metastases
|
|
670
|
|
|
‡a
Author's Infrared light-absorbing gold/gold sulfide nanoparticles induce cell death in esophageal adenocarcinoma.
|
|
670
|
|
|
‡a
Author's Intraoperative Esophagogastroduodenoscopy During Heller Myotomy: Evaluating Guidelines
|
|
670
|
|
|
‡a
Author's Intraoperative frozen section of sentinel nodes: a formal decision analysis
|
|
670
|
|
|
‡a
Author's Intraoperative magnetic resonance imaging for ablation of hepatic tumors
|
|
670
|
|
|
‡a
Author's Intrapancreatic accessory spleen
|
|
670
|
|
|
‡a
Author's Intrapancreatic accessory spleen (IPAS): A single-institution experience and review of the literature
|
|
670
|
|
|
‡a
Author's Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial
|
|
670
|
|
|
‡a
Author's Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated
|
|
670
|
|
|
‡a
Author's Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma.
|
|
670
|
|
|
‡a
Author's Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery
|
|
670
|
|
|
‡a
Author's Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival
|
|
670
|
|
|
‡a
Author's Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation
|
|
670
|
|
|
‡a
Author's Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma
|
|
670
|
|
|
‡a
Author's Is incisional biopsy of melanoma harmful?
|
|
670
|
|
|
‡a
Author's Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy?
|
|
670
|
|
|
‡a
Author's Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis
|
|
670
|
|
|
‡a
Author's Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?
|
|
670
|
|
|
‡a
Author's Kentucky hepatoma: epidemiologic variant or same problem in a different region?
|
|
670
|
|
|
‡a
Author's Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling
|
|
670
|
|
|
‡a
Author's Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice
|
|
670
|
|
|
‡a
Author's Laparoscopic hepatectomy is a safe and effective approach for resecting large colorectal liver metastases
|
|
670
|
|
|
‡a
Author's Laparoscopic hepatectomy significantly shortens the time to postoperative chemotherapy in patients undergoing major hepatectomies
|
|
670
|
|
|
‡a
Author's Laparoscopic hepatic lobectomy: advantages of a minimally invasive approach.
|
|
670
|
|
|
‡a
Author's Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula.
|
|
670
|
|
|
‡a
Author's Laparoscopic versus open hepatic resection for hepatocellular carcinoma: improvement in outcomes and similar cost
|
|
670
|
|
|
‡a
Author's Laparoscopic versus open resection of hepatic colorectal metastases
|
|
670
|
|
|
‡a
Author's Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches
|
|
670
|
|
|
‡a
Author's Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy
|
|
670
|
|
|
‡a
Author's Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis
|
|
670
|
|
|
‡a
Author's Long-term outcomes after hand-sewn versus circular-stapled
|
|
670
|
|
|
‡a
Author's Long-term outcomes after hand-sewn versus circular-stapled (25 and 29 mm) anastomotic technique after esophagogastrectomy for esophageal cancer.
|
|
670
|
|
|
‡a
Author's Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation
|
|
670
|
|
|
‡a
Author's Loss of manganese superoxide dismutase expression and activity in rat esophagus with external esophageal perfusion
|
|
670
|
|
|
‡a
Author's Low-energy DC current ablation in a mouse tumor model
|
|
670
|
|
|
‡a
Author's Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique
|
|
670
|
|
|
‡a
Author's Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients
|
|
670
|
|
|
‡a
Author's Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer
|
|
670
|
|
|
‡a
Author's Lymphovascular invasion as a prognostic factor in melanoma
|
|
670
|
|
|
‡a
Author's Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer
|
|
670
|
|
|
‡a
Author's Management of diffuse hepatocellular carcinoma (≧ 10 Lesions) with doxorubicin-loaded DC beads is a safe and effective treatment option
|
|
670
|
|
|
‡a
Author's Management of hepatic metastasis of gastrointestinal carcinoid tumors
|
|
670
|
|
|
‡a
Author's Manganese superoxide dismutase expression as a function of genotype and lung cancer pathology
|
|
670
|
|
|
‡a
Author's Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma
|
|
670
|
|
|
‡a
Author's Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence in general population
|
|
670
|
|
|
‡a
Author's Manganese superoxide dismutase V16A single-nucleotide polymorphism in the mitochondrial targeting sequence is associated with reduced enzymatic activity in cryopreserved human hepatocytes
|
|
670
|
|
|
‡a
Author's Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer
|
|
670
|
|
|
‡a
Author's Melanoma Patient-Reported Quality of Life Outcomes Following Sentinel Lymph Node Biopsy, Completion Lymphadenectomy, and Adjuvant Interferon: Results from the Sunbelt Melanoma Trial
|
|
670
|
|
|
‡a
Author's Method for determination of (-102C>T) single nucleotide polymorphism in the human manganese superoxide dismutase promoter
|
|
670
|
|
|
‡a
Author's Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes
|
|
670
|
|
|
‡a
Author's Microwave ablation for hepatic malignancies: a multiinstitutional analysis.
|
|
670
|
|
|
‡a
Author's Microwave hepatic ablation: initial experience of safety and efficacy
|
|
670
|
|
|
‡a
Author's Molecular changes in the esophageal epithelium after a subchronic exposure to cigarette smoke in the presence of bile-acid reflux.
|
|
670
|
|
|
‡a
Author's Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials
|
|
670
|
|
|
‡a
Author's Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence
|
|
670
|
|
|
‡a
Author's Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver
|
|
670
|
|
|
‡a
Author's Morphological transformation in esophageal submucosa by bone marrow cells: esophageal implantation under external esophageal perfusion
|
|
670
|
|
|
‡a
Author's Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy
|
|
670
|
|
|
‡a
Author's Multi-disciplinary management of locally advanced pancreatic cancer with irreversible electroporation
|
|
670
|
|
|
‡a
Author's Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection
|
|
670
|
|
|
‡a
Author's Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma
|
|
670
|
|
|
‡a
Author's Negative effects of transfused blood components after hepatectomy for metastatic colorectal cancer.
|
|
670
|
|
|
‡a
Author's Negative-pressure wound therapy does not reduce superficial SSI in pancreatectomy and hepatectomy procedures
|
|
670
|
|
|
‡a
Author's No apparent association between genetic polymorphisms
|
|
670
|
|
|
‡a
Author's No apparent association between genetic polymorphisms (-102 C>T) and (-9 T>C) in the human manganese superoxide dismutase gene and gastric cancer(1).
|
|
670
|
|
|
‡a
Author's Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy
|
|
670
|
|
|
‡a
Author's Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis
|
|
670
|
|
|
‡a
Author's Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival
|
|
670
|
|
|
‡a
Author's One-pot synthesis of magnesium nanoparticles embedded in a chitosan microparticle matrix: a highly biocompatible tool for in vivo cancer treatment
|
|
670
|
|
|
‡a
Author's Optimal Abdominal Incision for Partial Hepatectomy: Increased Late Complications with Mercedes-type Incisions Compared to Extended Right Subcostal Incisions
|
|
670
|
|
|
‡a
Author's Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin
|
|
670
|
|
|
‡a
Author's Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer
|
|
670
|
|
|
‡a
Author's Optimal radial force and size for palliation in gastroesophageal adenocarcinoma: a comparative analysis of current stent technology
|
|
670
|
|
|
‡a
Author's Outcomes after Laparoscopic Gastropexy as an Alternative for Paraesophageal Hernia Repair
|
|
670
|
|
|
‡a
Author's Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium.
|
|
670
|
|
|
‡a
Author's Outcomes and prognostic factors in nodular melanomas
|
|
670
|
|
|
‡a
Author's Outcomes and prognostic factors in superficial spreading melanoma
|
|
670
|
|
|
‡a
Author's Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy
|
|
670
|
|
|
‡a
Author's Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium
|
|
670
|
|
|
‡a
Author's Perception Is Reality: quality metrics in pancreas surgery - a Central Pancreas Consortium (CPC) analysis of 1399 patients
|
|
670
|
|
|
‡a
Author's Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.
|
|
670
|
|
|
‡a
Author's Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study.
|
|
670
|
|
|
‡a
Author's Permanent Loss of Preoperative Independence in Elderly Patients Undergoing Hepatectomy: Key Factor in the Informed Consent Process
|
|
670
|
|
|
‡a
Author's Phase II comparison study of intraoperative autotransfusion for major oncologic procedures
|
|
670
|
|
|
‡a
Author's Popliteal lymph node dissection
|
|
670
|
|
|
‡a
Author's Positive correlation of image analysis by mini-endoscopy with micro-PET scan and histology in rats after esophagoduodenal anastomosis.
|
|
670
|
|
|
‡a
Author's Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.
|
|
670
|
|
|
‡a
Author's Predicting patients at low probability of requiring postmastectomy radiation therapy
|
|
670
|
|
|
‡a
Author's Prediction of sentinel lymph node-only disease in women with invasive breast cancer
|
|
670
|
|
|
‡a
Author's Predictive preoperative and intraoperative factors of anastomotic leak in gastrectomy patients
|
|
670
|
|
|
‡a
Author's Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases
|
|
670
|
|
|
‡a
Author's Preoperative dosing of low-molecular-weight heparin in hepatopancreatobiliary surgery
|
|
670
|
|
|
‡a
Author's Preoperative performance status predicts outcome following heated intraperitoneal chemotherapy
|
|
670
|
|
|
‡a
Author's Primitive neuroectodermal tumor incidence, treatment patterns, and outcome: An analysis of the National Cancer Database
|
|
670
|
|
|
‡a
Author's Prior biliary tree instrumentation does not preclude hepatic arterial therapy for malignancy.
|
|
670
|
|
|
‡a
Author's Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes
|
|
670
|
|
|
‡a
Author's Prognostic factors in young women with cutaneous melanoma
|
|
670
|
|
|
‡a
Author's Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker
|
|
670
|
|
|
‡a
Author's Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study
|
|
670
|
|
|
‡a
Author's Prognostic information from sentinel lymph node biopsy in patients with thick melanoma
|
|
670
|
|
|
‡a
Author's Prognostic significance of tumor infiltrating lymphocytes in melanoma
|
|
670
|
|
|
‡a
Author's Progressive adoption of cryoablative therapy for breast fibroadenoma in community practice
|
|
670
|
|
|
‡a
Author's Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium.
|
|
670
|
|
|
‡a
Author's Proposed Staging System for Colon Carcinoid Tumors Based on an Analysis of 2,459 Patients
|
|
670
|
|
|
‡a
Author's Proposed staging system for gastrointestinal carcinoid tumors.
|
|
670
|
|
|
‡a
Author's Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
|
|
670
|
|
|
‡a
Author's Quality of complication reporting in the surgical literature
|
|
670
|
|
|
‡a
Author's Quality of life assessment for patients undergoing irreversible electroporation (IRE) for treatment of locally advanced pancreatic cancer (LAPC)
|
|
670
|
|
|
‡a
Author's Quality of survival reporting in chemotherapy and surgery trials in patients with metastatic colorectal carcinoma
|
|
670
|
|
|
‡a
Author's Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study
|
|
670
|
|
|
‡a
Author's Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?
|
|
670
|
|
|
‡a
Author's Randomized clinical trials in hepatocellular carcinoma and biliary cancer
|
|
670
|
|
|
‡a
Author's Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
|
|
670
|
|
|
‡a
Author's Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium
|
|
670
|
|
|
‡a
Author's Readmission rates after abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab
|
|
670
|
|
|
‡a
Author's recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival
|
|
670
|
|
|
‡a
Author's Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma
|
|
670
|
|
|
‡a
Author's Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma
|
|
670
|
|
|
‡a
Author's Restrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity
|
|
670
|
|
|
‡a
Author's Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity
|
|
670
|
|
|
‡a
Author's Risk stratification for readmission after major hepatectomy: development of a readmission risk score
|
|
670
|
|
|
‡a
Author's Role of esophageal stents in the nutrition support of patients with esophageal malignancy
|
|
670
|
|
|
‡a
Author's Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium
|
|
670
|
|
|
‡a
Author's Safety and advantages of combined resection and microwave ablation in patients with bilobar hepatic malignancies
|
|
670
|
|
|
‡a
Author's Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures
|
|
670
|
|
|
‡a
Author's Safety and efficacy of hepatectomy for colorectal metastases in the elderly.
|
|
670
|
|
|
‡a
Author's Safety and efficacy of irreversible electroporation in the treatment of obstructive jaundice in advanced hilar cholangiocarcinoma
|
|
670
|
|
|
‡a
Author's Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience
|
|
670
|
|
|
‡a
Author's Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review
|
|
670
|
|
|
‡a
Author's Safety, Efficacy, and Technical Details of Endoscopic Retrograde Cholangiopancreatography After Irreversible Electroporation for Locally Advanced Pancreatic Cancer
|
|
670
|
|
|
‡a
Author's Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy
|
|
670
|
|
|
‡a
Author's Second primary melanomas: incidence and outcome
|
|
670
|
|
|
‡a
Author's Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal
|
|
670
|
|
|
‡a
Author's Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer
|
|
670
|
|
|
‡a
Author's Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
|
|
670
|
|
|
‡a
Author's Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation?
|
|
670
|
|
|
‡a
Author's Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers?
|
|
670
|
|
|
‡a
Author's Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis
|
|
670
|
|
|
‡a
Author's Simultaneous versus staged resection for synchronous colorectal cancer liver metastases
|
|
670
|
|
|
‡a
Author's Single-stage resection and microwave ablation for bilobar colorectal liver metastases.
|
|
670
|
|
|
‡a
Author's Small versus large-sized drug-eluting beads
|
|
670
|
|
|
‡a
Author's Small versus large-sized drug-eluting beads (DEBIRI) for the treatment of hepatic colorectal metastases: a propensity score matching analysis.
|
|
670
|
|
|
‡a
Author's Soft tissue sarcoma of the extremity and trunk: issues for the general surgeon.
|
|
670
|
|
|
‡a
Author's Solid-pseudopapillary tumor of the pancreas: a surgical Enigma?
|
|
670
|
|
|
‡a
Author's Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: Observations from a US regional analysis of the GIDEON registry
|
|
670
|
|
|
‡a
Author's Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions
|
|
670
|
|
|
‡a
Author's Stroke volume variation in hepatic resection: a replacement for standard central venous pressure monitoring
|
|
670
|
|
|
‡a
Author's Surgeon and community factors affecting breast cancer sentinel lymph node biopsy
|
|
670
|
|
|
‡a
Author's Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study
|
|
670
|
|
|
‡a
Author's Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.
|
|
670
|
|
|
‡a
Author's Surveillance after surgical treatment of melanoma: Futility of routine chest radiography
|
|
670
|
|
|
‡a
Author's Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases.
|
|
670
|
|
|
‡a
Author's Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer
|
|
670
|
|
|
‡a
Author's The association of manganese superoxide dismutase expression in Barrett's esophageal progression with MnTBAP and curcumin oil therapy
|
|
670
|
|
|
‡a
Author's The diagnosis of pancreatic mucinous cystic neoplasm and associated adenocarcinoma in males: An eight-institution study of 349 patients over 15 years
|
|
670
|
|
|
‡a
Author's The effect of black raspberry extracts on MnSOD activity in protection against concanavalin A induced liver injury
|
|
670
|
|
|
‡a
Author's The effect of preoperative renal insufficiency on postoperative outcomes after major hepatectomy: a multi-institutional analysis of 1,170 patients
|
|
670
|
|
|
‡a
Author's The Effects of Travel Burden on Outcomes After Resection of Extrahepatic Biliary Malignancies: Results from the US Extrahepatic Biliary Consortium
|
|
670
|
|
|
‡a
Author's The Hand-Assisted Laparoscopic Approach to Resection of Pancreatic Mucinous Cystic Neoplasms: An Underused Technique?
|
|
670
|
|
|
‡a
Author's The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium
|
|
670
|
|
|
‡a
Author's The impact of enhanced recovery pathways on cost of care and perioperative outcomes in patients undergoing gastroesophageal and hepatopancreatobiliary surgery
|
|
670
|
|
|
‡a
Author's The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
|
|
670
|
|
|
‡a
Author's The impact of obesity on outcomes following pancreatectomy for malignancy
|
|
670
|
|
|
‡a
Author's The international position on laparoscopic liver surgery: The Louisville Statement, 2008.
|
|
670
|
|
|
‡a
Author's The lower incidence of melanoma in women may be related to increased preventative behaviors
|
|
670
|
|
|
‡a
Author's The lymph node ratio has limited prognostic significance in melanoma
|
|
670
|
|
|
‡a
Author's The prognostic significance of nonsentinel lymph node metastasis in melanoma
|
|
670
|
|
|
‡a
Author's The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients
|
|
670
|
|
|
‡a
Author's The resistance of esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide dismutase expression
|
|
670
|
|
|
‡a
Author's The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery
|
|
670
|
|
|
‡a
Author's The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: is there a standard for transfusion?
|
|
670
|
|
|
‡a
Author's The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty
|
|
670
|
|
|
‡a
Author's The use of self-expanding silicone stents in esophageal cancer care: optimal pre-, peri-, and postoperative care
|
|
670
|
|
|
‡a
Author's The use of self-expanding silicone stents in esophagectomy strictures: less cost and more efficiency
|
|
670
|
|
|
‡a
Author's Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry
|
|
670
|
|
|
‡a
Author's Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry
|
|
670
|
|
|
‡a
Author's Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations
|
|
670
|
|
|
‡a
Author's Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead
|
|
670
|
|
|
‡a
Author's Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations
|
|
670
|
|
|
‡a
Author's Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.
|
|
670
|
|
|
‡a
Author's Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy
|
|
670
|
|
|
‡a
Author's Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer
|
|
670
|
|
|
‡a
Author's Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma
|
|
670
|
|
|
‡a
Author's Ultrasound validation of mathematically modeled irreversible electroporation ablation areas
|
|
670
|
|
|
‡a
Author's Unique prognostic factors in acral lentiginous melanoma
|
|
670
|
|
|
‡a
Author's Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
|
|
670
|
|
|
‡a
Author's Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma
|
|
670
|
|
|
‡a
Author's Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry
|
|
670
|
|
|
‡a
Author's Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse Models
|
|
670
|
|
|
‡a
Author's Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy
|
|
670
|
|
|
‡a
Author's Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients
|
|
670
|
|
|
‡a
Author's Value of primary operative drain placement after major hepatectomy: a multi-institutional analysis of 1,041 patients.
|
|
670
|
|
|
‡a
Author's Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?
|
|
670
|
|
|
‡a
Author's Wide versus narrow margins after partial hepatectomy for hepatocellular carcinoma: Balancing recurrence risk and liver function
|
|
909
|
|
|
‡a
(orcid) 0000000255373387
‡9
1
|
|
919
|
|
|
‡a
literaturebasedtreatmentalgorithmforlowgradeneuroendocrinelivermetastases
‡A
A literature-based treatment algorithm for low-grade neuroendocrine liver metastases
‡9
1
|
|
919
|
|
|
‡a
costanalysisofearlybiliarystricturesfollowingorthotopiclivertransplantationintheunitedstates
‡A
A cost analysis of early biliary strictures following orthotopic liver transplantation in the United States
‡9
1
|
|
919
|
|
|
‡a
comparisonofprognosticschemesforperihilarcholangiocarcinoma
‡A
A Comparison of Prognostic Schemes for Perihilar Cholangiocarcinoma
‡9
1
|
|
919
|
|
|
‡a
costanalysisofsomatostatinuseinthepreventionofpancreaticfistulaafterpancreatectomy
‡A
A cost analysis of somatostatin use in the prevention of pancreatic fistula after pancreatectomy
‡9
1
|
|
919
|
|
|
‡a
wideversusnarrowmarginsafterpartialhepatectomyforhepatocellularcarcinomabalancingrecurrenceriskandliverfunction
‡A
Wide versus narrow margins after partial hepatectomy for hepatocellular carcinoma: Balancing recurrence risk and liver function
‡9
1
|
|
919
|
|
|
‡a
veininvolvementduringpancreaticoduodenectomyisthereaneedforredefinitionofborderlineresectabledisease
‡A
Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?
‡9
1
|
|
919
|
|
|
‡a
valueofprimaryoperativedrainplacementaftermajorhepatectomyamultiinstitutionalanalysisof1041patients
‡A
Value of primary operative drain placement after major hepatectomy: a multi-institutional analysis of 1,041 patients.
‡9
1
|
|
919
|
|
|
‡a
valueofintraoperativeneckmarginanalysisduringwhippleforpancreaticadenocarcinomaamulticenteranalysisof1399patients
‡A
Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients
‡9
1
|
|
919
|
|
|
‡a
validationofsubareolarandperiareolarinjectiontechniquesforbreastsentinellymphnodebiopsy
‡A
Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy
‡9
1
|
|
919
|
|
|
‡a
utilizingcontrastenhancedultrasoundimagingforevaluatingfattyliverdiseaseprogressioninpreclinicalmousemodels
‡A
Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse Models
‡9
1
|
|
919
|
|
|
‡a
useoftransarterialchemoembolizationtaceandsorafenibinpatientswithunresectablehepatocellularcarcinomausregionalanalysisofthegideonregistry
‡A
Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry
‡9
1
|
|
919
|
|
|
‡a
upregulationoffibroblastgrowthfactor19anditsreceptorassociateswithprogressionfromfattylivertohepatocellularcarcinoma
‡A
Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma
‡9
1
|
|
919
|
|
|
‡a
upregulationoffgf1519signalingpromoteshepatocellularcarcinomainthebackgroundoffattyliver
‡A
Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
‡9
1
|
|
919
|
|
|
‡a
uniqueprognosticfactorsinacrallentiginousmelanoma
‡A
Unique prognostic factors in acral lentiginous melanoma
‡9
1
|
|
919
|
|
|
‡a
ultrasoundvalidationofmathematicallymodeledirreversibleelectroporationablationareas
‡A
Ultrasound validation of mathematically modeled irreversible electroporation ablation areas
‡9
1
|
|
919
|
|
|
‡a
ulcerationasapredictivemarkerforresponsetoadjuvantinterferontherapyinmelanoma
‡A
Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma
‡9
1
|
|
919
|
|
|
‡a
tumorpositiveresectionmarginsreflectanaggressivetumorbiologyinpancreaticcancer
‡A
Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
treatmentof200locallyadvancedstage3pancreaticadenocarcinomapatientswithirreversibleelectroporationsafetyandefficacy
‡A
Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy
‡9
1
|
|
919
|
|
|
‡a
transplantationversusresectionforhilarcholangiocarcinomaanargumentforshiftingtreatmentparadigmsforresectabledisease
‡A
Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.
‡9
1
|
|
919
|
|
|
‡a
transcathetertreatmentofhepatocellularcarcinomawithdoxorubicinloaded600beaddebdoxtechnicalrecommendations
‡A
Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations
‡9
1
|
|
919
|
|
|
‡a
transcathetertreatmentofhepatocellularcarcinomawithdoxorubicinloaded600bead
‡A
Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead
‡9
1
|
|
919
|
|
|
‡a
transarterialtreatmentofcolorectalcancerlivermetastaseswithirinotecanloadeddrugelutingbeadstechnicalrecommendations
‡A
Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations
‡9
1
|
|
919
|
|
|
‡a
transarterialchemoembolizationofmetastaticcolorectalcarcinomawithdrugelutingbeadsirinotecandebirimultiinstitutionalregistry
‡A
Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry
‡9
1
|
|
919
|
|
|
‡a
toxicityofirinotecanelutingbeadsinthetreatmentofhepaticmalignanciesresultsofamultiinstitutionalregistry
‡A
Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry
‡9
1
|
|
919
|
|
|
‡a
useofselfexpandingsiliconestentsinesophagectomystrictureslesscostandmoreefficiency
‡A
The use of self-expanding silicone stents in esophagectomy strictures: less cost and more efficiency
‡9
1
|
|
919
|
|
|
‡a
useofselfexpandingsiliconestentsinesophagealcancercareoptimalpreperiandpostoperativecare
‡A
The use of self-expanding silicone stents in esophageal cancer care: optimal pre-, peri-, and postoperative care
‡9
1
|
|
919
|
|
|
‡a
useofradiationtherapyafterbreastconservingsurgeryinhormonallytreatedbreastcancerpatientsisdependentonpatientagegeographicregionandsurgeonspecialty
‡A
The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty
‡9
1
|
|
919
|
|
|
‡a
useoffreshfrozenplasmaaftermajorhepaticresectionforcolorectalmetastasisisthereastandardfortransfusion
‡A
The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: is there a standard for transfusion?
‡9
1
|
|
919
|
|
|
‡a
roleofhepaticarterylymphnodeinpancreaticadenocarcinomaprognosticfactororaselectioncriterionforsurgery
‡A
The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery
‡9
1
|
|
919
|
|
|
‡a
resistanceofesophagealadenocarcinomatobilesaltinsultisassociatedwithmanganesesuperoxidedismutaseexpression
‡A
The resistance of esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide dismutase expression
‡9
1
|
|
919
|
|
|
‡a
relationshipofbloodtransfusionwithperioperativeandlongtermoutcomesaftermajorhepatectomyformetastaticcolorectalcanceramultiinstitutionalstudyof456patients
‡A
The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients
‡9
1
|
|
919
|
|
|
‡a
prognosticsignificanceofnonsentinellymphnodemetastasisinmelanoma
‡A
The prognostic significance of nonsentinel lymph node metastasis in melanoma
‡9
1
|
|
919
|
|
|
‡a
lymphnoderatiohaslimitedprognosticsignificanceinmelanoma
‡A
The lymph node ratio has limited prognostic significance in melanoma
‡9
1
|
|
919
|
|
|
‡a
lowerincidenceofmelanomainwomenmayberelatedtoincreasedpreventativebehaviors
‡A
The lower incidence of melanoma in women may be related to increased preventative behaviors
‡9
1
|
|
919
|
|
|
‡a
internationalpositiononlaparoscopicliversurgerythelouisvillestatement
‡A
The international position on laparoscopic liver surgery: The Louisville Statement, 2008.
‡9
1
|
|
919
|
|
|
‡a
impactofobesityonoutcomesfollowingpancreatectomyformalignancy
‡A
The impact of obesity on outcomes following pancreatectomy for malignancy
‡9
1
|
|
919
|
|
|
‡a
impactofintraoperativereresectionofapositivebileductmarginonclinicaloutcomesforhilarcholangiocarcinoma
‡A
The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
‡9
1
|
|
919
|
|
|
‡a
impactofenhancedrecoverypathwaysoncostofcareandperioperativeoutcomesinpatientsundergoinggastroesophagealandhepatopancreatobiliarysurgery
‡A
The impact of enhanced recovery pathways on cost of care and perioperative outcomes in patients undergoing gastroesophageal and hepatopancreatobiliary surgery
‡9
1
|
|
919
|
|
|
‡a
impactofcaudateloberesectiononmarginstatusandoutcomesinpatientswithhilarcholangiocarcinomaamultiinstitutionalanalysisfromtheusextrahepaticbiliarymalignancyconsortium
‡A
The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium
‡9
1
|
|
919
|
|
|
‡a
handassistedlaparoscopicapproachtoresectionofpancreaticmucinouscysticneoplasmsanunderusedtechnique
‡A
The Hand-Assisted Laparoscopic Approach to Resection of Pancreatic Mucinous Cystic Neoplasms: An Underused Technique?
‡9
1
|
|
919
|
|
|
‡a
effectsoftravelburdenonoutcomesafterresectionofextrahepaticbiliarymalignanciesresultsfromtheusextrahepaticbiliaryconsortium
‡A
The Effects of Travel Burden on Outcomes After Resection of Extrahepatic Biliary Malignancies: Results from the US Extrahepatic Biliary Consortium
‡9
1
|
|
919
|
|
|
‡a
effectofpreoperativerenalinsufficiencyonpostoperativeoutcomesaftermajorhepatectomyamultiinstitutionalanalysisof1170patients
‡A
The effect of preoperative renal insufficiency on postoperative outcomes after major hepatectomy: a multi-institutional analysis of 1,170 patients
‡9
1
|
|
919
|
|
|
‡a
effectofblackraspberryextractsonmnsodactivityinprotectionagainstconcanavalinainducedliverinjury
‡A
The effect of black raspberry extracts on MnSOD activity in protection against concanavalin A induced liver injury
‡9
1
|
|
919
|
|
|
‡a
diagnosisofpancreaticmucinouscysticneoplasmandassociatedadenocarcinomainmalesan8institutionstudyof349patientsover15years
‡A
The diagnosis of pancreatic mucinous cystic neoplasm and associated adenocarcinoma in males: An eight-institution study of 349 patients over 15 years
‡9
1
|
|
919
|
|
|
‡a
associationofmanganesesuperoxidedismutaseexpressioninbarrettsesophagealprogressionwithmntbapandcurcuminoiltherapy
‡A
The association of manganese superoxide dismutase expression in Barrett's esophageal progression with MnTBAP and curcumin oil therapy
‡9
1
|
|
919
|
|
|
‡a
survivaloutcomesassociatedwithclinicalandpathologicalresponsefollowingneoadjuvantfolfirinoxorgemcitabinenabpaclitaxelchemotherapyinresectedpancreaticcancer
‡A
Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer
‡9
1
|
|
919
|
|
|
‡a
survivalafterresectionofperihilarcholangiocarcinomainpatientswithlymphnodemetastases
‡A
Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases.
‡9
1
|
|
919
|
|
|
‡a
surveillanceaftersurgicaltreatmentofmelanomafutilityofroutinechestradiography
‡A
Surveillance after surgical treatment of melanoma: Futility of routine chest radiography
‡9
1
|
|
919
|
|
|
‡a
surgicalsiteinfectionisassociatedwithtumorrecurrenceinpatientswithextrahepaticbiliarymalignancies
‡A
Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.
‡9
1
|
|
919
|
|
|
‡a
surgicaldownstagingandneoadjuvanttherapyinmetastaticcolorectalcarcinomawithirinotecandrugelutingbeadsamultiinstitutionalstudy
‡A
Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study
‡9
1
|
|
919
|
|
|
‡a
surgeonandcommunityfactorsaffectingbreastcancersentinellymphnodebiopsy
‡A
Surgeon and community factors affecting breast cancer sentinel lymph node biopsy
‡9
1
|
|
919
|
|
|
‡a
strokevolumevariationinhepaticresectionareplacementforstandardcentralvenouspressuremonitoring
‡A
Stroke volume variation in hepatic resection: a replacement for standard central venous pressure monitoring
‡9
1
|
|
919
|
|
|
‡a
staginglaparoscopyamong3subtypesofextrahepaticbiliarymalignancya15yearexperiencefrom10institutions
‡A
Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions
‡9
1
|
|
919
|
|
|
‡a
sorafenibuseforrecurrenthepatocellularcancerafterresectionortransplantationobservationsfromausregionalanalysisofthegideonregistry
‡A
Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: Observations from a US regional analysis of the GIDEON registry
‡9
1
|
|
919
|
|
|
‡a
solidpseudopapillarytumorofthepancreasasurgical Enigma
‡A
Solid-pseudopapillary tumor of the pancreas: a surgical Enigma?
‡9
1
|
|
919
|
|
|
‡a
softtissuesarcomaoftheextremityandtrunkissuesforthegeneralsurgeon
‡A
Soft tissue sarcoma of the extremity and trunk: issues for the general surgeon.
‡9
1
|
|
919
|
|
|
‡a
smallversuslargesizeddrugelutingbeadsdebiriforthetreatmentofhepaticcolorectalmetastasesapropensityscorematchinganalysis
‡A
Small versus large-sized drug-eluting beads (DEBIRI) for the treatment of hepatic colorectal metastases: a propensity score matching analysis.
‡9
1
|
|
919
|
|
|
‡a
smallversuslargesizeddrugelutingbeads
‡A
Small versus large-sized drug-eluting beads
‡9
1
|
|
919
|
|
|
‡a
singlestageresectionandmicrowaveablationforbilobarcolorectallivermetastases
‡A
Single-stage resection and microwave ablation for bilobar colorectal liver metastases.
‡9
1
|
|
919
|
|
|
‡a
simultaneousversusstagedresectionforsynchronouscolorectalcancerlivermetastases
‡A
Simultaneous versus staged resection for synchronous colorectal cancer liver metastases
‡9
1
|
|
919
|
|
|
‡a
simultaneousliverandcolorectalresectionsaresafeforsynchronouscolorectallivermetastasis
‡A
Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis
‡9
1
|
|
919
|
|
|
‡a
shouldsentinellymphnodebiopsybeusedroutinelyforstagingmelanomaandbreastcancers
‡A
Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers?
‡9
1
|
|
919
|
|
|
‡a
shouldhepaticmetastaticcolorectalcancerpatientswithextrahepaticdiseaseundergoliverresectionablation
‡A
Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation?
‡9
1
|
|
919
|
|
|
‡a
shouldallpatientswithmelanomabetween1and22000breslowthicknessundergosentinellymphnodebiopsy
‡A
Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
‡9
1
|
|
919
|
|
|
‡a
serologicalbiomarkersassociateultrasoundcharacteristicsofsteatohepatitisinmicewithlivercancer
‡A
Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer
‡9
1
|
|
919
|
|
|
‡a
sentinellymphnodebiopsyinpatientswithductalcarcinomainsituaproposal
‡A
Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal
‡9
1
|
|
919
|
|
|
‡a
2primarymelanomasincidenceandoutcome
‡A
Second primary melanomas: incidence and outcome
‡9
1
|
|
919
|
|
|
‡a
safetyofhepaticresectioninmetastaticdiseasetotheliverafteryttrium90therapy
‡A
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy
‡9
1
|
|
919
|
|
|
‡a
safetyefficacyandtechnicaldetailsofendoscopicretrogradecholangiopancreatographyafterirreversibleelectroporationforlocallyadvancedpancreaticcancer
‡A
Safety, Efficacy, and Technical Details of Endoscopic Retrograde Cholangiopancreatography After Irreversible Electroporation for Locally Advanced Pancreatic Cancer
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyoftransarterialchemoembolizationwithdrugelutingbeadsinhepatocellularcancerasystematicreview
‡A
Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofmicrowaveablationofhepatictumorsaprospectivereviewofa5yearexperience
‡A
Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofirreversibleelectroporationinthetreatmentofobstructivejaundiceinadvancedhilarcholangiocarcinoma
‡A
Safety and efficacy of irreversible electroporation in the treatment of obstructive jaundice in advanced hilar cholangiocarcinoma
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofhepatectomyforcolorectalmetastasesintheelderly
‡A
Safety and efficacy of hepatectomy for colorectal metastases in the elderly.
‡9
1
|
|
919
|
|
|
‡a
safetyandearlyefficacyofirreversibleelectroporationforhepatictumorsinproximitytovitalstructures
‡A
Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures
‡9
1
|
|
919
|
|
|
‡a
safetyandadvantagesofcombinedresectionandmicrowaveablationinpatientswithbilobarhepaticmalignancies
‡A
Safety and advantages of combined resection and microwave ablation in patients with bilobar hepatic malignancies
‡9
1
|
|
919
|
|
|
‡a
routineportsiteexcisioninincidentallydiscoveredgallbladdercancerisnotassociatedwithimprovedsurvivalamultiinstitutionanalysisfromtheusextrahepaticbiliarymalignancyconsortium
‡A
Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium
‡9
1
|
|
919
|
|
|
‡a
roleofesophagealstentsinthenutritionsupportofpatientswithesophagealmalignancy
‡A
Role of esophageal stents in the nutrition support of patients with esophageal malignancy
‡9
1
|
|
919
|
|
|
‡a
riskstratificationforreadmissionaftermajorhepatectomydevelopmentofareadmissionriskscore
‡A
Risk stratification for readmission after major hepatectomy: development of a readmission risk score
‡9
1
|
|
919
|
|
|
‡a
restrictivebloodtransfusionprotocolinmalignantuppergastrointestinalandpancreaticresectionspatientsreducesbloodtransfusionswithnoincreaseinpatientmorbidity
‡A
Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity
‡9
1
|
|
919
|
|
|
‡a
restrictivebloodtransfusionprotocolinliverresectionpatientsreducesbloodtransfusionswithnoincreaseinpatientmorbidity
‡A
Restrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity
‡9
1
|
|
919
|
|
|
‡a
regressiondoesnotpredictnodalmetastasisorsurvivalinpatientswithcutaneousmelanoma
‡A
Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma
‡9
1
|
|
919
|
|
|
‡a
refluxinjuryofesophagealmucosaexperimentalstudiesinanimalmodelsofesophagitisbarrettsesophagusandesophagealadenocarcinoma
‡A
Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett's esophagus and esophageal adenocarcinoma
‡9
1
|
|
919
|
|
|
‡a
recurrencefollowinghepatectomyformetastaticcolorectalcancerdevelopmentofamodelthatpredictspatternsofrecurrenceandsurvival
‡A
recurrence following hepatectomy for metastatic colorectal cancer: development of a model that predicts patterns of recurrence and survival
‡9
1
|
|
919
|
|
|
‡a
readmissionratesafterabdominalsurgerytheroleofsurgeonprimarycaregiverhomehealthandsubacuterehab
‡A
Readmission rates after abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab
‡9
1
|
|
919
|
|
|
‡a
ratesandpatternsofrecurrenceaftercurativeintentresectionforgallbladdercanceramultiinstitutionanalysisfromtheusextrahepaticbiliarymalignancyconsortium
‡A
Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium
‡9
1
|
|
919
|
|
|
‡a
randomizedcontrolledtrialofirinotecandrugelutingbeadswithsimultaneousfolfoxandbevacizumabforpatientswithunresectablecolorectalliverlimitedmetastasis
‡A
Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
‡9
1
|
|
919
|
|
|
‡a
randomizedclinicaltrialsinhepatocellularcarcinomaandbiliarycancer
‡A
Randomized clinical trials in hepatocellular carcinoma and biliary cancer
‡9
1
|
|
919
|
|
|
‡a
radiofrequencyablationvsresectionforhepaticcolorectalmetastasistherapeuticallyequivalent
‡A
Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?
‡9
1
|
|
919
|
|
|
‡a
radioembolizationversuschemoembolizationdebdoxforthetreatmentofunresectablehepatocellularcarcinomaapropensitymatchedstudy
‡A
Radioembolization Versus Chemoembolization (DEBDOX) for the Treatment of Unresectable Hepatocellular Carcinoma: A Propensity Matched Study
‡9
1
|
|
919
|
|
|
‡a
qualityofsurvivalreportinginchemotherapyandsurgerytrialsinpatientswithmetastaticcolorectalcarcinoma
‡A
Quality of survival reporting in chemotherapy and surgery trials in patients with metastatic colorectal carcinoma
‡9
1
|
|
919
|
|
|
‡a
qualityoflifeassessmentforpatientsundergoingirreversibleelectroporationirefortreatmentoflocallyadvancedpancreaticcancerlapc
‡A
Quality of life assessment for patients undergoing irreversible electroporation (IRE) for treatment of locally advanced pancreatic cancer (LAPC)
‡9
1
|
|
919
|
|
|
‡a
qualityofcomplicationreportinginthesurgicalliterature
‡A
Quality of complication reporting in the surgical literature
‡9
1
|
|
919
|
|
|
‡a
prospectivemultiinstitutionalstudyofreversetranscriptasepolymerasechainreactionformolecularstagingofmelanoma
‡A
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
‡9
1
|
|
919
|
|
|
‡a
proposedstagingsystemforgastrointestinalcarcinoidtumors
‡A
Proposed staging system for gastrointestinal carcinoid tumors.
‡9
1
|
|
919
|
|
|
‡a
proposedstagingsystemforcoloncarcinoidtumorsbasedonananalysisof2459patients
‡A
Proposed Staging System for Colon Carcinoid Tumors Based on an Analysis of 2,459 Patients
‡9
1
|
|
919
|
|
|
‡a
proposalforanewtstageclassificationsystemfordistalcholangiocarcinomaa10institutionstudyfromtheusextrahepaticbiliarymalignancyconsortium
‡A
Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium.
‡9
1
|
|
919
|
|
|
‡a
progressiveadoptionofcryoablativetherapyforbreastfibroadenomaincommunitypractice
‡A
Progressive adoption of cryoablative therapy for breast fibroadenoma in community practice
‡9
1
|
|
919
|
|
|
‡a
prognosticsignificanceoftumorinfiltratinglymphocytesinmelanoma
‡A
Prognostic significance of tumor infiltrating lymphocytes in melanoma
‡9
1
|
|
919
|
|
|
‡a
prognosticinformationfromsentinellymphnodebiopsyinpatientswiththickmelanoma
‡A
Prognostic information from sentinel lymph node biopsy in patients with thick melanoma
‡9
1
|
|
919
|
|
|
‡a
prognosticimplicationsoflymphnodestatusforpatientswithgallbladdercanceramultiinstitutionalstudy
‡A
Prognostic Implications of Lymph Node Status for Patients With Gallbladder Cancer: A Multi-Institutional Study
‡9
1
|
|
919
|
|
|
‡a
prognosticimplicationsofanatomiclocationofprimarycutaneousmelanomaof12000orthicker
‡A
Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker
‡9
1
|
|
919
|
|
|
‡a
prognosticfactorsinyoungwomenwithcutaneousmelanoma
‡A
Prognostic factors in young women with cutaneous melanoma
‡9
1
|
|
919
|
|
|
‡a
prognosticfactorsinmelanomapatientswithtumornegativesentinellymphnodes
‡A
Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes
‡9
1
|
|
919
|
|
|
‡a
priorbiliarytreeinstrumentationdoesnotprecludehepaticarterialtherapyformalignancy
‡A
Prior biliary tree instrumentation does not preclude hepatic arterial therapy for malignancy.
‡9
1
|
|
919
|
|
|
‡a
primitiveneuroectodermaltumorincidencetreatmentpatternsandoutcomeananalysisofthenationalcancerdatabase
‡A
Primitive neuroectodermal tumor incidence, treatment patterns, and outcome: An analysis of the National Cancer Database
‡9
1
|
|
919
|
|
|
‡a
preoperativeperformancestatuspredictsoutcomefollowingheatedintraperitonealchemotherapy
‡A
Preoperative performance status predicts outcome following heated intraperitoneal chemotherapy
‡9
1
|
|
919
|
|
|
‡a
preoperativedosingoflowmolecularweightheparininhepatopancreatobiliarysurgery
‡A
Preoperative dosing of low-molecular-weight heparin in hepatopancreatobiliary surgery
‡9
1
|
|
919
|
|
|
‡a
preoperativechemotherapydoesnotincreasemorbidityormortalityofhepaticresectionforcolorectalcancermetastases
‡A
Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases
‡9
1
|
|
919
|
|
|
‡a
predictivepreoperativeandintraoperativefactorsofanastomoticleakingastrectomypatients
‡A
Predictive preoperative and intraoperative factors of anastomotic leak in gastrectomy patients
‡9
1
|
|
919
|
|
|
‡a
predictionofsentinellymphnodeonlydiseaseinwomenwithinvasivebreastcancer
‡A
Prediction of sentinel lymph node-only disease in women with invasive breast cancer
‡9
1
|
|
919
|
|
|
‡a
predictingpatientsatlowprobabilityofrequiringpostmastectomyradiationtherapy
‡A
Predicting patients at low probability of requiring postmastectomy radiation therapy
‡9
1
|
|
919
|
|
|
‡a
precisionhepaticarterialirinotecantherapyinthetreatmentofunresectableintrahepaticcholangiocellularcarcinomaoptimaltoleranceandprolongedoverallsurvival
‡A
Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.
‡9
1
|
|
919
|
|
|
‡a
positivecorrelationofimageanalysisbyminiendoscopywithmicropetscanandhistologyinratsafteresophagoduodenalanastomosis
‡A
Positive correlation of image analysis by mini-endoscopy with micro-PET scan and histology in rats after esophagoduodenal anastomosis.
‡9
1
|
|
919
|
|
|
‡a
popliteallymphnodedissection
‡A
Popliteal lymph node dissection
‡9
1
|
|
919
|
|
|
‡a
phase2comparisonstudyofintraoperativeautotransfusionformajoroncologicprocedures
‡A
Phase II comparison study of intraoperative autotransfusion for major oncologic procedures
‡9
1
|
|
919
|
|
|
‡a
permanentlossofpreoperativeindependenceinelderlypatientsundergoinghepatectomykeyfactorintheinformedconsentprocess
‡A
Permanent Loss of Preoperative Independence in Elderly Patients Undergoing Hepatectomy: Key Factor in the Informed Consent Process
‡9
1
|
|
919
|
|
|
‡a
perioperativebloodtransfusionisassociatedwithdecreasedsurvivalinpatientsundergoingpancreaticoduodenectomyforpancreaticadenocarcinomaamultiinstitutionalstudy
‡A
Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study.
‡9
1
|
|
919
|
|
|
‡a
perihilarcholangiocarcinomanumberofnodesexaminedandoptimallymphnodeprognosticscheme
‡A
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.
‡9
1
|
|
919
|
|
|
‡a
perceptionisrealityqualitymetricsinpancreassurgeryacentralpancreasconsortiumcpcanalysisof1399patients
‡A
Perception Is Reality: quality metrics in pancreas surgery - a Central Pancreas Consortium (CPC) analysis of 1399 patients
‡9
1
|
|
919
|
|
|
‡a
pathologicandprognosticimplicationsofincidentalversusnonincidentalgallbladdercancera10institutionstudyfromtheunitedstatesextrahepaticbiliarymalignancyconsortium
‡A
Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium
‡9
1
|
|
919
|
|
|
‡a
overallsurvivalperihilarcholangiocarcinomar1resectionwithcurativeintentcomparedtoprimaryendoscopictherapy
‡A
Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy
‡9
1
|
|
919
|
|
|
‡a
outcomesandprognosticfactorsinsuperficialspreadingmelanoma
‡A
Outcomes and prognostic factors in superficial spreading melanoma
‡9
1
|
|
919
|
|
|
‡a
outcomesandprognosticfactorsinnodularmelanomas
‡A
Outcomes and prognostic factors in nodular melanomas
‡9
1
|
|
919
|
|
|
‡a
outcomesaftervascularresectionduringcurativeintentresectionforhilarcholangiocarcinomaamultiinstitutionstudyfromtheusextrahepaticbiliarymalignancyconsortium
‡A
Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium.
‡9
1
|
|
919
|
|
|
‡a
outcomesafterlaparoscopicgastropexyasanalternativeforparaesophagealherniarepair
‡A
Outcomes after Laparoscopic Gastropexy as an Alternative for Paraesophageal Hernia Repair
‡9
1
|
|
919
|
|
|
‡a
optimalradialforceandsizeforpalliationingastroesophagealadenocarcinomaacomparativeanalysisofcurrentstenttechnology
‡A
Optimal radial force and size for palliation in gastroesophageal adenocarcinoma: a comparative analysis of current stent technology
‡9
1
|
|
919
|
|
|
‡a
optimalperfusionchemotherapyaprospectivecomparisonofmitomycin100andoxaliplatinforhyperthermicintraperitonealchemotherapyinmetastaticcoloncancer
‡A
Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer
‡9
1
|
|
919
|
|
|
‡a
optimaloutcomesforliverdominantmetastaticbreastcancerwithtransarterialchemoembolizationwithdrugelutingbeadsloadedwithdoxorubicin
‡A
Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin
‡9
1
|
|
919
|
|
|
‡a
optimalabdominalincisionforpartialhepatectomyincreasedlatecomplicationswithmercedestypeincisionscomparedtoextendedrightsubcostalincisions
‡A
Optimal Abdominal Incision for Partial Hepatectomy: Increased Late Complications with Mercedes-type Incisions Compared to Extended Right Subcostal Incisions
‡9
1
|
|
919
|
|
|
‡a
1potsynthesisofmagnesiumnanoparticlesembeddedinachitosanmicroparticlematrixahighlybiocompatibletoolforinvivocancertreatment
‡A
One-pot synthesis of magnesium nanoparticles embedded in a chitosan microparticle matrix: a highly biocompatible tool for in vivo cancer treatment
‡9
1
|
|
919
|
|
|
‡a
oncologiceffectsofpreoperativebiliarydrainageinresectablehilarcholangiocarcinomapercutaneousbiliarydrainagehasnoadverseeffectsonsurvival
‡A
Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival
‡9
1
|
|
919
|
|
|
‡a
obesityratherthanneoadjuvantchemotherapypredictssteatohepatitisinpatientswithcolorectalmetastasis
‡A
Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis
‡9
1
|
|
919
|
|
|
‡a
nutritionalsupportwithendoluminalstentingduringneoadjuvanttherapyforesophagealmalignancy
‡A
Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy
‡9
1
|
|
919
|
|
|
‡a
noapparentassociationbetweengeneticpolymorphisms102100tand9t100inthehumanmanganesesuperoxidedismutasegeneandgastriccancer1
‡A
No apparent association between genetic polymorphisms (-102 C>T) and (-9 T>C) in the human manganese superoxide dismutase gene and gastric cancer(1).
‡9
1
|
|
919
|
|
|
‡a
noapparentassociationbetweengeneticpolymorphisms
‡A
No apparent association between genetic polymorphisms
‡9
1
|
|
919
|
|
|
‡a
negativepressurewoundtherapydoesnotreducesuperficialssiinpancreatectomyandhepatectomyprocedures
‡A
Negative-pressure wound therapy does not reduce superficial SSI in pancreatectomy and hepatectomy procedures
‡9
1
|
|
919
|
|
|
‡a
negativeeffectsoftransfusedbloodcomponentsafterhepatectomyformetastaticcolorectalcancer
‡A
Negative effects of transfused blood components after hepatectomy for metastatic colorectal cancer.
‡9
1
|
|
919
|
|
|
‡a
multiinstitutionalanalysisofrecurrenceandsurvivalafterhepatectomyforfibrolamellarcarcinoma
‡A
Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma
‡9
1
|
|
919
|
|
|
‡a
multiinstitutionalanalysisofpancreaticadenocarcinomademonstratingtheeffectofdiabetesstatusonsurvivalafterresection
‡A
Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection
‡9
1
|
|
919
|
|
|
‡a
multidisciplinarymanagementoflocallyadvancedpancreaticcancerwithirreversibleelectroporation
‡A
Multi-disciplinary management of locally advanced pancreatic cancer with irreversible electroporation
‡9
1
|
|
919
|
|
|
‡a
multidisciplinaryconcurrentmanagementofrecurrenthepatocellulartherapyissuperiortosequentialtherapy
‡A
Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy
‡9
1
|
|
919
|
|
|
‡a
morphologicaltransformationinesophagealsubmucosabybonemarrowcellsesophagealimplantationunderexternalesophagealperfusion
‡A
Morphological transformation in esophageal submucosa by bone marrow cells: esophageal implantation under external esophageal perfusion
‡9
1
|
|
919
|
|
|
‡a
morbidityofadjuvanthepaticarterialinfusionpumpchemotherapyinthemanagementofcolorectalcancermetastatictotheliver
‡A
Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver
‡9
1
|
|
919
|
|
|
‡a
molecularstagingofsentinellymphnodesidentifiesmelanomapatientsatincreasedriskofnodalrecurrence
‡A
Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence
‡9
1
|
|
919
|
|
|
‡a
molecularfactorsassociatedwithrecurrenceandsurvivalfollowinghepatectomyinpatientswithintrahepaticcholangiocarcinomaaguidetoadjuvantclinicaltrials
‡A
Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials
‡9
1
|
|
919
|
|
|
‡a
molecularchangesintheesophagealepitheliumafterasubchronicexposuretocigarettesmokeinthepresenceofbileacidreflux
‡A
Molecular changes in the esophageal epithelium after a subchronic exposure to cigarette smoke in the presence of bile-acid reflux.
‡9
1
|
|
919
|
|
|
‡a
microwavehepaticablationinitialexperienceofsafetyandefficacy
‡A
Microwave hepatic ablation: initial experience of safety and efficacy
‡9
1
|
|
919
|
|
|
‡a
microwaveablationforhepaticmalignanciesamultiinstitutionalanalysis
‡A
Microwave ablation for hepatic malignancies: a multiinstitutional analysis.
‡9
1
|
|
919
|
|
|
‡a
microwaveablationforhepaticmalignanciesacallforstandardreportingandoutcomes
‡A
Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes
‡9
1
|
|
919
|
|
|
‡a
methodfordeterminationof102ctsinglenucleotidepolymorphisminthehumanmanganesesuperoxidedismutasepromoter
‡A
Method for determination of (-102C>T) single nucleotide polymorphism in the human manganese superoxide dismutase promoter
‡9
1
|
|
919
|
|
|
‡a
melanomapatientreportedqualityoflifeoutcomesfollowingsentinellymphnodebiopsycompletionlymphadenectomyandadjuvantinterferonresultsfromthesunbeltmelanomatrial
‡A
Melanoma Patient-Reported Quality of Life Outcomes Following Sentinel Lymph Node Biopsy, Completion Lymphadenectomy, and Adjuvant Interferon: Results from the Sunbelt Melanoma Trial
‡9
1
|
|
919
|
|
|
‡a
medicallymanagedhypercholesterolemiaandinsulindependentdiabetesmellituspreoperativelypredictspoorsurvivalaftersurgeryforpancreaticcancer
‡A
Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
manganesesuperoxidedismutasev16asinglenucleotidepolymorphisminthemitochondrialtargetingsequenceisassociatedwithreducedenzymaticactivityincryopreservedhumanhepatocytes
‡A
Manganese superoxide dismutase V16A single-nucleotide polymorphism in the mitochondrial targeting sequence is associated with reduced enzymatic activity in cryopreserved human hepatocytes
‡9
1
|
|
919
|
|
|
‡a
manganesesuperoxidedismutasegenecodingregionpolymorphismslackclinicalincidenceingeneralpopulation
‡A
Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence in general population
‡9
1
|
|
919
|
|
|
‡a
manganesesuperoxidedismutaseexpressionisnegativelyassociatedwithmicrorna301ainhumanpancreaticductaladenocarcinoma
‡A
Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma
‡9
1
|
|
919
|
|
|
‡a
manganesesuperoxidedismutaseexpressionasafunctionofgenotypeandlungcancerpathology
‡A
Manganese superoxide dismutase expression as a function of genotype and lung cancer pathology
‡9
1
|
|
919
|
|
|
‡a
managementofhepaticmetastasisofgastrointestinalcarcinoidtumors
‡A
Management of hepatic metastasis of gastrointestinal carcinoid tumors
‡9
1
|
|
919
|
|
|
‡a
managementofdiffusehepatocellularcarcinoma10lesionswithdoxorubicinloaded600beadsisasafeandeffectivetreatmentoption
‡A
Management of diffuse hepatocellular carcinoma (≧ 10 Lesions) with doxorubicin-loaded DC beads is a safe and effective treatment option
‡9
1
|
|
919
|
|
|
‡a
majorhepatectomywithsimultaneouspancreatectomyforadvancedhepatobiliarycancer
‡A
Major hepatectomy with simultaneous pancreatectomy for advanced hepatobiliary cancer
‡9
1
|
|
919
|
|
|
‡a
lymphovascularinvasionasaprognosticfactorinmelanoma
‡A
Lymphovascular invasion as a prognostic factor in melanoma
‡9
1
|
|
919
|
|
|
‡a
lymphnoderatioisasignificantpredictorofdiseasespecificmortalityinpatientsundergoingesophagectomyforcancer
‡A
Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer
‡9
1
|
|
919
|
|
|
‡a
lymphnoderatioaproposedrefinementofcurrentaxillarystaginginbreastcancerpatients
‡A
Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients
‡9
1
|
|
919
|
|
|
‡a
lumpectomymarginsareaffectedbytumorsizeandhistologicsubtypebutnotbybiopsytechnique
‡A
Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique
‡9
1
|
|
919
|
|
|
‡a
lowenergy600currentablationinamousetumormodel
‡A
Low-energy DC current ablation in a mouse tumor model
‡9
1
|
|
919
|
|
|
‡a
lossofmanganesesuperoxidedismutaseexpressionandactivityinratesophaguswithexternalesophagealperfusion
‡A
Loss of manganese superoxide dismutase expression and activity in rat esophagus with external esophageal perfusion
‡9
1
|
|
919
|
|
|
‡a
lossoffgf21indiabeticmouseduringhepatocellularcarcinogenetictransformation
‡A
Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation
‡9
1
|
|
919
|
|
|
‡a
longtermoutcomesafterhandsewnversuscircularstapled25and292000anastomotictechniqueafteresophagogastrectomyforesophagealcancer
‡A
Long-term outcomes after hand-sewn versus circular-stapled (25 and 29 mm) anastomotic technique after esophagogastrectomy for esophageal cancer.
‡9
1
|
|
919
|
|
|
‡a
longtermoutcomesafterhandsewnversuscircularstapled
‡A
Long-term outcomes after hand-sewn versus circular-stapled
‡9
1
|
|
919
|
|
|
‡a
liverdirectedsurgeryformetastaticsquamouscellcarcinomatotheliverresultsofamulticenteranalysis
‡A
Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis
‡9
1
|
|
919
|
|
|
‡a
livercelladenomaamulticenteranalysisofriskfactorsforruptureandmalignancy
‡A
Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy
‡9
1
|
|
919
|
|
|
‡a
leftsidedpancreatectomyamulticentercomparisonoflaparoscopicandopenapproaches
‡A
Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches
‡9
1
|
|
919
|
|
|
‡a
laparoscopicversusopenresectionofhepaticcolorectalmetastases
‡A
Laparoscopic versus open resection of hepatic colorectal metastases
‡9
1
|
|
919
|
|
|
‡a
laparoscopicversusopenhepaticresectionforhepatocellularcarcinomaimprovementinoutcomesandsimilarcost
‡A
Laparoscopic versus open hepatic resection for hepatocellular carcinoma: improvement in outcomes and similar cost
‡9
1
|
|
919
|
|
|
‡a
laparoscopicleftpancreatectomycomplicationriskscorecorrelateswithmorbidityandriskforpancreaticfistula
‡A
Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula.
‡9
1
|
|
919
|
|
|
‡a
laparoscopichepaticlobectomyadvantagesofaminimallyinvasiveapproach
‡A
Laparoscopic hepatic lobectomy: advantages of a minimally invasive approach.
‡9
1
|
|
919
|
|
|
‡a
laparoscopichepatectomysignificantlyshortensthetimetopostoperativechemotherapyinpatientsundergoingmajorhepatectomies
‡A
Laparoscopic hepatectomy significantly shortens the time to postoperative chemotherapy in patients undergoing major hepatectomies
‡9
1
|
|
919
|
|
|
‡a
laparoscopichepatectomyisasafeandeffectiveapproachforresectinglargecolorectallivermetastases
‡A
Laparoscopic hepatectomy is a safe and effective approach for resecting large colorectal liver metastases
‡9
1
|
|
919
|
|
|
‡a
lackoffibroblastgrowthfactor21acceleratesmetabolicliverinjurycharacterizedbysteatohepatitiesinmice
‡A
Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice
‡9
1
|
|
919
|
|
|
‡a
lackoffgf21promotesnashhcctransitionviahepatocytetlr4il17asignaling
‡A
Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling
‡9
1
|
|
919
|
|
|
‡a
kentuckyhepatomaepidemiologicvariantorsameprobleminadifferentregion
‡A
Kentucky hepatoma: epidemiologic variant or same problem in a different region?
‡9
1
|
|
919
|
|
|
‡a
isselectiveinternalradioembolizationsafeandeffectiveforpatientswithinoperablehepatocellularcarcinomaandvenousthrombosis
‡A
Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?
‡9
1
|
|
919
|
|
|
‡a
isradioembolization90ybetterthandoxorubicindrugelutingbeadsdebdoxforhepatocellularcarcinomawithportalveinthrombosisaretrospectiveanalysis
‡A
Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis
‡9
1
|
|
919
|
|
|
‡a
ispriorcholecystectomyassociatedwithdecreasedsurvivalinpatientswithresectablepancreaticadenocarcinomafollowingpancreaticoduodenectomy
‡A
Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy?
‡9
1
|
|
919
|
|
|
‡a
isincisionalbiopsyofmelanomaharmful
‡A
Is incisional biopsy of melanoma harmful?
‡9
1
|
|
919
|
|
|
‡a
irreversibleelectroporationtherapyinthemanagementoflocallyadvancedpancreaticadenocarcinoma
‡A
Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma
‡9
1
|
|
919
|
|
|
‡a
irreversibleelectroporationofunresectablesofttissuetumorswithvascularinvasioneffectivepalliation
‡A
Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation
‡9
1
|
|
919
|
|
|
‡a
irreversibleelectroporationinlocallyadvancedpancreaticcancerpotentialimprovedoverallsurvival
‡A
Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival
‡9
1
|
|
919
|
|
|
‡a
irreversibleelectroporationinlocallyadvancedpancreaticcanceracallforstandardizationofenergydelivery
‡A
Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery
‡9
1
|
|
919
|
|
|
‡a
irreversibleelectroporationenhancesdeliveryofgemcitabinetopancreaticadenocarcinoma
‡A
Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma.
‡9
1
|
|
919
|
|
|
‡a
irreversibleelectroporationablationireofunresectablesofttissuetumorslearningcurveevaluationinthe1150patientstreated
‡A
Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated
‡9
1
|
|
919
|
|
|
‡a
irinotecandrugelutingbeadsinthetreatmentofchemonaiveunresectablecolorectallivermetastasiswithconcomitantsystemicfluorouracilandoxaliplatinresultsofpharmacokineticsandphase1trial
‡A
Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial
‡9
1
|
|
919
|
|
|
‡a
intrapancreaticaccessoryspleenipasasingleinstitutionexperienceandreviewoftheliterature
‡A
Intrapancreatic accessory spleen (IPAS): A single-institution experience and review of the literature
‡9
1
|
|
919
|
|
|
‡a
intrapancreaticaccessoryspleen
‡A
Intrapancreatic accessory spleen
‡9
1
|
|
919
|
|
|
‡a
intraoperativemagneticresonanceimagingforablationofhepatictumors
‡A
Intraoperative magnetic resonance imaging for ablation of hepatic tumors
‡9
1
|
|
919
|
|
|
‡a
intraoperativefrozensectionofsentinelnodesaformaldecisionanalysis
‡A
Intraoperative frozen section of sentinel nodes: a formal decision analysis
‡9
1
|
|
919
|
|
|
‡a
intraoperativeesophagogastroduodenoscopyduringhellermyotomyevaluatingguidelines
‡A
Intraoperative Esophagogastroduodenoscopy During Heller Myotomy: Evaluating Guidelines
‡9
1
|
|
919
|
|
|
‡a
infraredlightabsorbinggoldgoldsulfidenanoparticlesinducecelldeathinesophagealadenocarcinoma
‡A
Infrared light-absorbing gold/gold sulfide nanoparticles induce cell death in esophageal adenocarcinoma.
‡9
1
|
|
919
|
|
|
‡a
infectiouscomplicationsincombinedcolonresectionandablationofcolorectallivermetastases
‡A
Infectious complications in combined colon resection and ablation of colorectal liver metastases
‡9
1
|
|
919
|
|
|
‡a
incompletethermalablationofhepatocellularcarcinomaeffectsontumorproliferation
‡A
Incomplete thermal ablation of hepatocellular carcinoma: effects on tumor proliferation
‡9
1
|
|
919
|
|
|
‡a
incidenceofsentinellymphnodeinvolvementinamodernlargeseriesofdesmoplasticmelanoma
‡A
Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma
‡9
1
|
|
919
|
|
|
‡a
importanceoflowpreoperativeplateletcountinselectingpatientsforresectionofhepatocellularcarcinomaamultiinstitutionalanalysis
‡A
Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis
‡9
1
|
|
919
|
|
|
‡a
implementationofprehabilitationformajorabdominalsurgeryandheadandnecksurgeryasimplified7dayprotocol
‡A
Implementation of Prehabilitation for Major Abdominal Surgery and Head and Neck Surgery: a Simplified Seven-Day Protocol
‡9
1
|
|
919
|
|
|
‡a
impactofsurgicalmarginclearanceforresectionofsecondaryhepaticmalignancies
‡A
Impact of surgical margin clearance for resection of secondary hepatic malignancies
‡9
1
|
|
919
|
|
|
‡a
impactofpostoperativecomplicationsonqualityoflifeafterpancreatectomy
‡A
Impact of post-operative complications on quality of life after pancreatectomy
‡9
1
|
|
919
|
|
|
‡a
impactofperfusateglucoseconcentrationonperioperativeoutcomesinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
‡A
Impact of Perfusate Glucose Concentration on Perioperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
‡9
1
|
|
919
|
|
|
‡a
impactofhistologyonsurvivalinretroperitonealsarcomas
‡A
Impact of histology on survival in retroperitoneal sarcomas
‡9
1
|
|
919
|
|
|
‡a
impactofchemotherapyandexternalbeamradiationtherapyonoutcomesamongpatientswithresectedgallbladdercanceramultiinstitutionalanalysis
‡A
Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis
‡9
1
|
|
919
|
|
|
‡a
imagedguidedtransarterialchemoembolizationwithdrugelutingbeadsloadedwithdoxorubicindebdoxforhepaticmetastasesfrommelanomaearlyoutcomesfromamultiinstitutionalregistry
‡A
Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a multi-institutional registry
‡9
1
|
|
919
|
|
|
‡a
imagedguidedtransarterialchemoembolizationwithdrugelutingbeadsloadedwithdoxorubicin
‡A
Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin
‡9
1
|
|
919
|
|
|
‡a
imageofthemonthpapillarylowgradeneuroendocrinetumorofthepancreaswithpancreaticductdilation
‡A
Image of the month. Papillary low-grade neuroendocrine tumor of the pancreas with pancreatic duct dilation
‡9
1
|
|
919
|
|
|
‡a
imageguidedtransarterialchemoembolizationwithdrugelutingbeadsloadedwithdoxorubicindebdoxforunresectablehepaticmetastasesfrommelanomatechniqueandoutcomes
‡A
Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes
‡9
1
|
|
919
|
|
|
‡a
imageguidedtransarterialchemoembolizationwithdrugelutingbeadsloadedwithdoxorubicin
‡A
Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin
‡9
1
|
|
919
|
|
|
‡a
identifyingriskfactorfordevelopmentofperioperativevenousthromboembolisminpatientswithgastrointestinalmalignancy
‡A
Identifying risk factor for development of perioperative venous thromboembolism in patients with gastrointestinal malignancy
‡9
1
|
|
919
|
|
|
‡a
highriskpopulationinsporadicpancreaticadenocarcinomaguidelinesforscreening
‡A
High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening
‡9
1
|
|
919
|
|
|
‡a
highnacetyltransferase1nat1expressionisassociatedwithestrogenreceptorexpressioninbreasttumorsbutisnotunderdirectregulationbyestradiol17betadiolordihydrotestosteroneinbreastcancercells
‡A
High N-acetyltransferase 1 (NAT1) expression is associated with estrogen receptor expression in breast tumors, but is not under direct regulation by estradiol, 17beta-diol, or dihydrotestosterone in breast cancer cells
‡9
1
|
|
919
|
|
|
‡a
herbalmedicineandhepatocellularcarcinomaapplicationsandchallenges
‡A
Herbal medicine and hepatocellular carcinoma: applications and challenges
‡9
1
|
|
919
|
|
|
‡a
hepatictumorablationwithclusteredmicrowaveantennaetheusphase2trial
‡A
Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial
‡9
1
|
|
919
|
|
|
‡a
hepaticprotectionandanticanceractivityofcurcumaapotentialchemopreventivestrategyagainsthepatocellularcarcinoma
‡A
Hepatic protection and anticancer activity of curcuma: a potential chemopreventive strategy against hepatocellular carcinoma
‡9
1
|
|
919
|
|
|
‡a
hepaticmalignantepithelioidhemangioendotheliomaacasereportandreviewoftheliterature
‡A
Hepatic malignant epithelioid hemangioendothelioma: a case report and review of the literature
‡9
1
|
|
919
|
|
|
‡a
hepaticintraductaloncocyticpapillarycarcinoma
‡A
Hepatic intraductal oncocytic papillary carcinoma
‡9
1
|
|
919
|
|
|
‡a
hepaticintraarterialinjectionofdrugelutingbeadirinotecandebiriinunresectablecolorectallivermetastasesrefractorytosystemicchemotherapyresultsofmultiinstitutionalstudy
‡A
Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study
‡9
1
|
|
919
|
|
|
‡a
hepaticimagingcharacteristicspredictoverallsurvivalinhepatocellularcarcinoma
‡A
Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma.
‡9
1
|
|
919
|
|
|
‡a
hepaticarterialtherapywithdrugelutingbeadsinthemanagementofmetastaticpancreaticcarcinomatotheliveramultiinstitutionalregistry
‡A
Hepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry
‡9
1
|
|
919
|
|
|
‡a
hepaticarterialtherapywithdrugelutingbeadsinthemanagementofmetastaticbronchogeniccarcinomatotheliveramultiinstitutionalregistry
‡A
Hepatic arterial therapy with drug-eluting beads in the management of metastatic bronchogenic carcinoma to the liver: a multi-institutional registry
‡9
1
|
|
919
|
|
|
‡a
hepaticarterialtherapyasabridgetoablationortransplantinthetreatmentofhepatocellularcarcinoma
‡A
Hepatic arterial therapy as a bridge to ablation or transplant in the treatment of hepatocellular carcinoma.
‡9
1
|
|
919
|
|
|
‡a
hepaticarterialinfusionofdoxorubicinloadedmicrospherefortreatmentofhepatocellularcanceramultiinstitutionalregistry
‡A
Hepatic arterial infusion of doxorubicin-loaded microsphere for treatment of hepatocellular cancer: a multi-institutional registry
‡9
1
|
|
919
|
|
|
‡a
hepatectomyissuperiortothermalablationforpatientswithasolitarycolorectallivermetastasis
‡A
Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis
‡9
1
|
|
919
|
|
|
‡a
hepatectomyafterhepaticarterialtherapywitheitheryttrium90ordrugelutingbeadchemotherapyisitsafe
‡A
Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?
‡9
1
|
|
919
|
|
|
‡a
healthrelatedqualityoflifereturntobaselineaftermajorandminorliverresection
‡A
Health-related quality of life: return to baseline after major and minor liver resection.
‡9
1
|
|
919
|
|
|
‡a
healthrelatedqualityoflifeduringtransarterialchemoembolizationwithdrugelutingbeadsloadedwithdoxorubicindebdoxforunresectablehepaticmetastasesfromocularmelanoma
‡A
Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from ocular melanoma
‡9
1
|
|
919
|
|
|
‡a
healthrelatedqualityoflifeduringtransarterialchemoembolizationwithdrugelutingbeadsloadedwithdoxorubicin
‡A
Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin
‡9
1
|
|
919
|
|
|
‡a
healthrelatedqualityoflifechangesfollowingmajorandminorhepaticresectiontheimpactofcomplicationsandpostoperativeanemia
‡A
Health-related quality of life changes following major and minor hepatic resection: the impact of complications and postoperative anemia
‡9
1
|
|
919
|
|
|
‡a
gradingusingki67indexandmitoticrateincreasestheprognosticaccuracyofpancreaticneuroendocrinetumors
‡A
Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors
‡9
1
|
|
919
|
|
|
‡a
goldnanorodsandcurcuminloadednanomicellesforefficientinvivophotothermaltherapyofbarrettsesophagus
‡A
Gold nanorods and curcumin-loaded nanomicelles for efficient in vivo photothermal therapy of Barrett's esophagus
‡9
1
|
|
919
|
|
|
‡a
genderrelateddifferencesinoutcomeformelanomapatients
‡A
Gender-related differences in outcome for melanoma patients
‡9
1
|
|
919
|
|
|
‡a
gastroesophagealrefluxdiseaserelatedsymptomassessmentinsubjectswithmalignantdysphagiareceivingesophagealstents
‡A
Gastroesophageal reflux disease-related symptom assessment in subjects with malignant dysphagia receiving esophageal stents.
‡9
1
|
|
919
|
|
|
‡a
gastricesophagealstentingformalignantdysphagiaresultsofprospectiveclinicaltrialevaluationoflongtermgastroesophagealrefluxandqualityofliferelatedsymptoms
‡A
Gastric-Esophageal Stenting for Malignant Dysphagia: Results of Prospective Clinical Trial Evaluation of Long-Term Gastroesophageal Reflux and Quality of Life-Related Symptoms
‡9
1
|
|
919
|
|
|
‡a
gallbladdercancerpresentingwithjaundiceuniformlyfatalorstillpotentiallycurable
‡A
Gallbladder Cancer Presenting with Jaundice: Uniformly Fatal or Still Potentially Curable?
‡9
1
|
|
919
|
|
|
‡a
fineneedleaspirationcytologyintheevaluationofpatientswithradiographicallyoccultpalpablebreastabnormalities
‡A
Fine-needle aspiration cytology in the evaluation of patients with radiographically occult, palpable breast abnormalities
‡9
1
|
|
919
|
|
|
‡a
financialcomparisonoflaparoscopicversusopenhepaticresectionusingdeviationbasedcostmodeling
‡A
Financial comparison of laparoscopic versus open hepatic resection using deviation-based cost modeling
‡9
1
|
|
919
|
|
|
‡a
finalresultsofthesunbeltmelanomatrialamultiinstitutionalprospectiverandomizedphase3studyevaluatingtheroleofadjuvanthighdoseinterferonalfa2bandcompletionlymphnodedissectionforpatientsstagedbysentinellymphnodebi
‡A
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Bi
‡9
1
|
|
919
|
|
|
‡a
factorspredictiveofreadmissionafterhepaticresectionforhepatocellularcarcinoma
‡A
Factors predictive of readmission after hepatic resection for hepatocellular carcinoma
‡9
1
|
|
919
|
|
|
‡a
factorspredictingfailuretoidentifyasentinellymphnodeinbreastcancer
‡A
Factors predicting failure to identify a sentinel lymph node in breast cancer
‡9
1
|
|
919
|
|
|
‡a
factorsinfluencingtimetodecreaseinintraoperativeparathyroidhormoneiopthlevelsinpatientsundergoingfocusedparathyroidectomyfp
‡A
Factors Influencing Time to Decrease in Intraoperative Parathyroid Hormone (ioPTH) Levels in Patients Undergoing Focused Parathyroidectomy (FP)
‡9
1
|
|
919
|
|
|
‡a
factorsinfluencingreadmissionafterpancreaticoduodenectomyamultiinstitutionalstudyof1302patients
‡A
Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients
‡9
1
|
|
919
|
|
|
‡a
factorsdeterminingadequacyofaxillarynodedissectioninbreastcancerpatients
‡A
Factors determining adequacy of axillary node dissection in breast cancer patients
‡9
1
|
|
919
|
|
|
‡a
factorsassociatedwithsurgicaloptionsforbreastcarcinoma
‡A
Factors associated with surgical options for breast carcinoma
‡9
1
|
|
919
|
|
|
‡a
factorsassociatedwithrecurrenceandsurvivalfollowinghepatectomyforlargehepatocellularcarcinomaamulticenteranalysis
‡A
Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis
‡9
1
|
|
919
|
|
|
‡a
factorsassociatedwithimprovedsurvivalamongyoungadultmelanomapatientsdespiteagreaterincidenceofsentinellymphnodemetastasis
‡A
Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
‡9
1
|
|
919
|
|
|
‡a
factorsassociatedwithfalsenegativesentinellymphnodebiopsyinmelanomapatients
‡A
Factors associated with false-negative sentinel lymph node biopsy in melanoma patients
‡9
1
|
|
943
|
|
|
‡a
200x
‡A
2008
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000029911722
|
|
996
|
|
|
‡2
SUDOC|126209413
|
|
996
|
|
|
‡2
NTA|332905683
|
|
996
|
|
|
‡2
LC|n 2018069867
|
|
996
|
|
|
‡2
LC|n 2024022017
|
|
996
|
|
|
‡2
ISNI|0000000049027272
|
|
996
|
|
|
‡2
SUDOC|078394341
|
|
996
|
|
|
‡2
ISNI|0000000120948606
|
|
996
|
|
|
‡2
CAOONL|ncf11358023
|
|
996
|
|
|
‡2
BNF|15021105
|
|
996
|
|
|
‡2
CAOONL|ncf10976098
|
|
996
|
|
|
‡2
ISNI|0000000110575260
|
|
996
|
|
|
‡2
ISNI|0000000001601407
|
|
996
|
|
|
‡2
ISNI|000000005253593X
|
|
996
|
|
|
‡2
CAOONL|ncf11867225
|
|
996
|
|
|
‡2
LIH|LNB:DQ_b_J;=BX
|
|
996
|
|
|
‡2
SUDOC|02976484X
|
|
996
|
|
|
‡2
BNF|14119357
|
|
996
|
|
|
‡2
ISNI|0000000079012530
|
|
996
|
|
|
‡2
PLWABN|9810604513405606
|
|
996
|
|
|
‡2
NKC|zmp2016937349
|
|
996
|
|
|
‡2
NKC|osd2013771864
|
|
996
|
|
|
‡2
J9U|987007361276105171
|
|
996
|
|
|
‡2
ISNI|0000000059896316
|
|
996
|
|
|
‡2
DNB|1017097933
|
|
996
|
|
|
‡2
LC|n 92122468
|
|
996
|
|
|
‡2
BLBNB|000510470
|
|
996
|
|
|
‡2
BNCHL|10000000000000000009595
|
|
996
|
|
|
‡2
BNE|XX1158671
|
|
996
|
|
|
‡2
B2Q|0000457652
|
|
996
|
|
|
‡2
NTA|240058631
|
|
996
|
|
|
‡2
LC|no2016014010
|
|
996
|
|
|
‡2
ISNI|0000000038627088
|
|
996
|
|
|
‡2
NUKAT|n 2009051061
|
|
996
|
|
|
‡2
BNF|12330827
|
|
996
|
|
|
‡2
LIH|LNB:V-101701;=_y__h_
|
|
996
|
|
|
‡2
ISNI|0000000078979416
|
|
996
|
|
|
‡2
NUKAT|n 2014053543
|
|
996
|
|
|
‡2
ISNI|0000000111265782
|
|
996
|
|
|
‡2
SUDOC|034615075
|
|
996
|
|
|
‡2
DNB|1150417269
|
|
996
|
|
|
‡2
DNB|1213911222
|
|
996
|
|
|
‡2
SUDOC|184452473
|
|
996
|
|
|
‡2
RERO|A023732083
|
|
996
|
|
|
‡2
LC|n 90681244
|
|
996
|
|
|
‡2
SUDOC|234845694
|
|
996
|
|
|
‡2
PLWABN|9810636458605606
|
|
996
|
|
|
‡2
ISNI|0000000081218263
|
|
996
|
|
|
‡2
BNF|11475104
|
|
996
|
|
|
‡2
J9U|987012197468105171
|
|
996
|
|
|
‡2
BNE|XX4722807
|
|
996
|
|
|
‡2
J9U|987007400700405171
|
|
996
|
|
|
‡2
BNF|12498568
|
|
996
|
|
|
‡2
BIBSYS|90179413
|
|
996
|
|
|
‡2
CAOONL|ncf12078724
|
|
996
|
|
|
‡2
LC|nb2021000336
|
|
996
|
|
|
‡2
DNB|1080093869
|
|
996
|
|
|
‡2
ISNI|0000000029292837
|
|
996
|
|
|
‡2
NTA|071420177
|
|
996
|
|
|
‡2
RERO|A003566800
|
|
996
|
|
|
‡2
LC|no 99040182
|
|
996
|
|
|
‡2
ISNI|0000000114380022
|
|
996
|
|
|
‡2
BNE|XX1784463
|
|
996
|
|
|
‡2
DNB|1240247966
|
|
996
|
|
|
‡2
LC|no2007001047
|
|
996
|
|
|
‡2
RERO|A003566788
|
|
996
|
|
|
‡2
RERO|A003566789
|
|
996
|
|
|
‡2
NTA|138815003
|
|
996
|
|
|
‡2
DNB|1146659679
|
|
996
|
|
|
‡2
J9U|987007288421705171
|
|
996
|
|
|
‡2
DNB|1036996964
|
|
996
|
|
|
‡2
J9U|987007353464205171
|
|
996
|
|
|
‡2
JPG|500116467
|
|
996
|
|
|
‡2
SUDOC|03512332X
|
|
996
|
|
|
‡2
ISNI|0000000446966599
|
|
996
|
|
|
‡2
SUDOC|059442611
|
|
996
|
|
|
‡2
BNF|12133425
|
|
996
|
|
|
‡2
NII|DA08954161
|
|
996
|
|
|
‡2
NLA|000036031024
|
|
996
|
|
|
‡2
ISNI|0000000030421835
|
|
996
|
|
|
‡2
LC|no 99040183
|
|
996
|
|
|
‡2
CAOONL|ncf11519771
|
|
996
|
|
|
‡2
J9U|987007312728405171
|
|
996
|
|
|
‡2
ISNI|0000000021793063
|
|
996
|
|
|
‡2
NUKAT|n 97018546
|
|
996
|
|
|
‡2
NTA|133439739
|
|
996
|
|
|
‡2
LC|n 89609407
|
|
996
|
|
|
‡2
NLA|000035331054
|
|
996
|
|
|
‡2
RERO|A012401577
|
|
996
|
|
|
‡2
LC|no2011036962
|
|
996
|
|
|
‡2
SUDOC|071359214
|
|
996
|
|
|
‡2
BNF|14978696
|
|
996
|
|
|
‡2
ISNI|0000000001631593
|
|
996
|
|
|
‡2
LC|no2010016266
|
|
996
|
|
|
‡2
LC|no2011045617
|
|
996
|
|
|
‡2
NTA|128918675
|
|
996
|
|
|
‡2
LC|n 90725742
|
|
996
|
|
|
‡2
LC|nb2013024823
|
|
996
|
|
|
‡2
PLWABN|9810636733805606
|
|
996
|
|
|
‡2
SUDOC|244788561
|
|
996
|
|
|
‡2
LC|no2009052893
|
|
996
|
|
|
‡2
SUDOC|156290170
|
|
996
|
|
|
‡2
LC|n 83181825
|
|
996
|
|
|
‡2
RERO|A003566738
|
|
996
|
|
|
‡2
SUDOC|249149885
|
|
996
|
|
|
‡2
J9U|987007358005605171
|
|
996
|
|
|
‡2
LC|nb2008006715
|
|
996
|
|
|
‡2
LC|no2011103722
|
|
996
|
|
|
‡2
ISNI|0000000041573981
|
|
996
|
|
|
‡2
RERO|A012418799
|
|
996
|
|
|
‡2
DNB|1233337041
|
|
996
|
|
|
‡2
LC|n 2004002962
|
|
996
|
|
|
‡2
NUKAT|n 97036008
|
|
996
|
|
|
‡2
NUKAT|n 2018163667
|
|
996
|
|
|
‡2
LC|n 86096904
|
|
996
|
|
|
‡2
DNB|1330584783
|
|
996
|
|
|
‡2
DNB|1089772637
|
|
996
|
|
|
‡2
SUDOC|055309879
|
|
996
|
|
|
‡2
NII|DA11154334
|
|
996
|
|
|
‡2
ISNI|0000000139820370
|
|
996
|
|
|
‡2
ISNI|0000000021503273
|
|
996
|
|
|
‡2
ERRR|12301796
|
|
996
|
|
|
‡2
NII|DA01911604
|
|
996
|
|
|
‡2
DNB|174007485
|
|
996
|
|
|
‡2
J9U|987011288674005171
|
|
996
|
|
|
‡2
ISNI|0000000383727821
|
|
996
|
|
|
‡2
NTA|323924786
|
|
996
|
|
|
‡2
DNB|17389075X
|
|
996
|
|
|
‡2
LC|n 94049520
|
|
996
|
|
|
‡2
SUDOC|070351503
|
|
996
|
|
|
‡2
BNE|XX1138122
|
|
996
|
|
|
‡2
BIBSYS|99037504
|
|
996
|
|
|
‡2
LC|n 2022010078
|
|
996
|
|
|
‡2
NII|DA02578169
|
|
996
|
|
|
‡2
NLA|000035331082
|
|
996
|
|
|
‡2
BNE|XX1595784
|
|
996
|
|
|
‡2
ISNI|0000000434908199
|
|
996
|
|
|
‡2
ISNI|0000000077565676
|
|
996
|
|
|
‡2
ISNI|0000000035138852
|
|
996
|
|
|
‡2
LC|no2007157147
|
|
996
|
|
|
‡2
SUDOC|251075184
|
|
996
|
|
|
‡2
N6I|vtls000069798
|
|
996
|
|
|
‡2
SUDOC|192953494
|
|
996
|
|
|
‡2
ISNI|0000000073578963
|
|
996
|
|
|
‡2
LC|n 77017520
|
|
996
|
|
|
‡2
NTA|068459157
|
|
996
|
|
|
‡2
LC|nb2009012720
|
|
996
|
|
|
‡2
B2Q|0000471183
|
|
996
|
|
|
‡2
ISNI|000000003814940X
|
|
996
|
|
|
‡2
BNE|XX1318403
|
|
996
|
|
|
‡2
BNF|14530894
|
|
996
|
|
|
‡2
PLWABN|9810593059005606
|
|
996
|
|
|
‡2
LC|n 80063214
|
|
996
|
|
|
‡2
DNB|1138308358
|
|
996
|
|
|
‡2
DNB|174322437
|
|
996
|
|
|
‡2
J9U|987007326458905171
|
|
996
|
|
|
‡2
CAOONL|ncf11395218
|
|
996
|
|
|
‡2
ISNI|0000000514185437
|
|
996
|
|
|
‡2
J9U|987007279652005171
|
|
996
|
|
|
‡2
DNB|120145111
|
|
996
|
|
|
‡2
J9U|987007265033305171
|
|
996
|
|
|
‡2
LC|no2011014161
|
|
996
|
|
|
‡2
ISNI|000000003802616X
|
|
996
|
|
|
‡2
LC|no2018174821
|
|
996
|
|
|
‡2
BNF|12180068
|
|
996
|
|
|
‡2
NDL|00864364
|
|
996
|
|
|
‡2
ISNI|0000000075743256
|
|
996
|
|
|
‡2
J9U|987007426494805171
|
|
996
|
|
|
‡2
SUDOC|181064375
|
|
996
|
|
|
‡2
ISNI|0000000006914533
|
|
996
|
|
|
‡2
LC|n 92804655
|
|
996
|
|
|
‡2
PLWABN|9810557319005606
|
|
996
|
|
|
‡2
ISNI|0000000032641030
|
|
996
|
|
|
‡2
BLBNB|000389913
|
|
996
|
|
|
‡2
ISNI|0000000076182948
|
|
996
|
|
|
‡2
DNB|124485766
|
|
996
|
|
|
‡2
LC|n 97038188
|
|
996
|
|
|
‡2
ISNI|0000000025958240
|
|
996
|
|
|
‡2
RERO|A009660735
|
|
996
|
|
|
‡2
BNF|16522110
|
|
996
|
|
|
‡2
LC|n 88260620
|
|
996
|
|
|
‡2
LC|n 2011060522
|
|
996
|
|
|
‡2
SUDOC|149799446
|
|
996
|
|
|
‡2
ISNI|0000000366967372
|
|
996
|
|
|
‡2
ISNI|0000000039076329
|
|
996
|
|
|
‡2
ISNI|0000000140002121
|
|
996
|
|
|
‡2
ISNI|0000000110818832
|
|
996
|
|
|
‡2
LC|n 88195061
|
|
996
|
|
|
‡2
LIH|LNB:CN6_g_;=BU
|
|
996
|
|
|
‡2
DNB|119145766
|
|
996
|
|
|
‡2
LC|n 82079996
|
|
996
|
|
|
‡2
ISNI|0000000365876102
|
|
996
|
|
|
‡2
CAOONL|ncf10025299
|
|
996
|
|
|
‡2
SUDOC|03095939X
|
|
996
|
|
|
‡2
LC|n 87130873
|
|
996
|
|
|
‡2
BNF|15590664
|
|
996
|
|
|
‡2
LC|n 87142306
|
|
996
|
|
|
‡2
NUKAT|n 2010163318
|
|
996
|
|
|
‡2
LC|no2014050775
|
|
996
|
|
|
‡2
LC|nb2011010045
|
|
996
|
|
|
‡2
SUDOC|134487184
|
|
996
|
|
|
‡2
SUDOC|249227304
|
|
996
|
|
|
‡2
NUKAT|n 2004026257
|
|
996
|
|
|
‡2
BNF|12740469
|
|
996
|
|
|
‡2
BNF|12100870
|
|
996
|
|
|
‡2
NKC|xx0221011
|
|
996
|
|
|
‡2
LC|no 99070240
|
|
996
|
|
|
‡2
ISNI|0000000391260344
|
|
996
|
|
|
‡2
LIH|LNB:CBE_f_;=BG
|
|
996
|
|
|
‡2
ISNI|0000000079729267
|
|
996
|
|
|
‡2
BNF|14506002
|
|
996
|
|
|
‡2
LC|no2013117483
|
|
996
|
|
|
‡2
BNE|XX1133299
|
|
996
|
|
|
‡2
LC|n 2014027760
|
|
996
|
|
|
‡2
NTA|240058984
|
|
996
|
|
|
‡2
LC|nb 98094780
|
|
996
|
|
|
‡2
ISNI|000000050446693X
|
|
996
|
|
|
‡2
ISNI|0000000139127066
|
|
996
|
|
|
‡2
BNF|12145198
|
|
996
|
|
|
‡2
DBC|87097991515202
|
|
996
|
|
|
‡2
BNCHL|10000000000000000197476
|
|
996
|
|
|
‡2
BIBSYS|90133937
|
|
996
|
|
|
‡2
DNB|1305051165
|
|
996
|
|
|
‡2
DNB|1251579612
|
|
996
|
|
|
‡2
DNB|1146446152
|
|
996
|
|
|
‡2
SUDOC|029511518
|
|
996
|
|
|
‡2
ISNI|0000000000204514
|
|
996
|
|
|
‡2
NII|DA00198699
|
|
996
|
|
|
‡2
BNF|18170395
|
|
996
|
|
|
‡2
ISNI|0000000001800430
|
|
996
|
|
|
‡2
DNB|134600398
|
|
996
|
|
|
‡2
JPG|500032679
|
|
996
|
|
|
‡2
ISNI|0000000042019341
|
|
996
|
|
|
‡2
CAOONL|ncf10360524
|
|
996
|
|
|
‡2
CAOONL|ncf10088015
|
|
996
|
|
|
‡2
N6I|vtls000074476
|
|
996
|
|
|
‡2
NTA|071841970
|
|
996
|
|
|
‡2
BNF|12310504
|
|
996
|
|
|
‡2
BNC|981058518489806706
|
|
996
|
|
|
‡2
ISNI|0000000420350307
|
|
996
|
|
|
‡2
BNF|13326664
|
|
996
|
|
|
‡2
NUKAT|n 2007119528
|
|
996
|
|
|
‡2
BNF|12500781
|
|
996
|
|
|
‡2
ISNI|0000000024947160
|
|
996
|
|
|
‡2
SUDOC|03508264X
|
|
996
|
|
|
‡2
DNB|1119454328
|
|
996
|
|
|
‡2
NTA|075187108
|
|
996
|
|
|
‡2
SIMACOB|172664675
|
|
996
|
|
|
‡2
SUDOC|102560390
|
|
996
|
|
|
‡2
NII|DA01015659
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
